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To acquire fertilizing ability, mammalian sperm undergo a series of biochemical 
and physiological changes collectively known as capacitation1,2. At the molecular level, 
capacitation is associated with a fast bicarbonate (HCO3-)-dependent activation of a 
unique type of soluble adenyl cyclase (sAC) and a consequent increase in cyclic AMP 
(cAMP) levels and PKA activation3. Activation of a cAMP/PKA pathway results in the 
phosphorylation of PKA substrates, which in turn initiates activation of several signaling 
cascades ultimately leading to an increase in phosphorylation on tyrosine residues (P-
Tyr) of sperm axonemal proteins4,5. Increase in P-Tyr has been associated to sperm 
hyperactivation, an asymmetric and whip-like motion of the sperm tail necessary for 
fertilization4,6.  
Although the increase in protein phosphorylation associated with mouse sperm 
capacitation is well established, the identity of the proteins involved in this signaling 
cascade remains largely unknown. Tandem mass spectrometry (MS/MS) has been used 
to identify the exact sites of phosphorylation and to compare the relative extent of 
phosphorylation at these sites7–9. As a part of the work on Chapter 2, we found that a 
novel site of phosphorylation on a peptide derived from the radial spoke protein Rsph6a 
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is highly phosphorylated in capacitated mouse sperm. Phylogenetic analysis showed that 
Rsph6a gene contains six exons, five of which are conserved during evolution in 
flagellated cells. The exon containing the capacitation-induced phosphorylation site was 
found exclusively in eutherian mammals. Transcript analyses revealed at least two 
different testis-specific splicing variants for Rsph6a. Rsph6a mRNA expression was 
restricted to spermatocytes. Using antibodies generated against the Rsph6a N-terminal 
domain, western blotting and immunofluorescence analyses indicated that the protein 
remains in mature sperm and localizes to the sperm flagellum. Consistent with its role in 
the axoneme, solubility analyses revealed that Rsph6 is attached to cytoskeletal 
structures. Based on previous studies in Chlamydomonas reinhardtii, we predict that 
Rsph6 participates in the interaction between the central pair of microtubules and the 
surrounding pairs. The findings that Rsph6a is more phosphorylated during capacitation 
and is predicted to function in axonemal localization make Rsph6a a candidate protein 
mediating signaling processes in the sperm flagellum.  
Besides HCO3-, the role of Ca2+ in capacitation pathway is indispensable.  Ca2+ 
regulates cAMP/PKA pathway through direct stimulation of sAC3. Ca2+ also binds to 
another binding partner calmodulin (CaM) and regulates activity of multiple enzymes such 
as phosphodiesterases (PDEs), protein phosphatase 2B (PP2B, also known as 
calcineurin), and to protein kinases; Ca2+/CaM-dependent kinase II (CaMKII) and 
Ca2+/CaM-dependent kinase IV (CaMKIV)10. The role of Ca2+ and Ca2+/CaM in sperm 
capacitation was demonstrated by genetic and pharmacological approaches. Mice 
lacking CatSper, a sperm specific Ca2+ channel, failed to hyperactive and displayed 
aberrant/premature P-Tyr of sperm axonemal proteins, and consequently were infertile11–
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14. Consistently, inhibition of CaM inhibitors also inhibited onset of sperm 
hyperactivation15. Nonetheless, the role of downstream targets of Ca2+/CaM in 
capacitation process is not well understood. 
cAMP controls several signaling events during sperm capacitation and its levels 
during this process are quite dynamic. Depending on the need to fine tune PKA signaling, 
its levels are regulated by constant synthesis and degradation events. Such dynamics in 
cAMP levels can be explained by crosstalk between cAMP and Ca2+ signaling pathways. 
On one hand, Ca2+ positively promotes cAMP synthesis by direct stimulation of sAC3,16; 
on the other hand, Ca2+ binds to calmodulin (CaM), which activates a phosphodiesterase 
(PDE) and promotes cAMP degradation17–19. Besides PDE, PKA has been shown to 
control cAMP synthesis in a negative feedback loop by direct or indirect phosphorylation 
of sAC20. However, there is no clear understanding as to how this feedback loop is 
regulated, and how it fine-tunes PKA signaling during capacitation. As a part of this work 
on Chapter 3, we showed that calcineurin, a Ser/Thr phosphatase, is involved in this 
process. Inhibition of calcineurin by calcineurin inhibitors such as Cyclosporin A (CsA) 
and FK506 negatively PKA substrate phosphorylation. By measuring PKA and sAC 
activity in vitro in the presence of calcineurin inhibitors, we demonstrated that inhibition of 
PKA substrate phosphorylation is not due to off-target effect of the pharmacological 
drugs. Furthermore, we hypothesized that calcineurin being a Ser/Thr phosphatase, is 
able to activate sAC and thus regulates cAMP levels during sperm capacitation. 
Consistently, calcineurin inhibitors significantly reduced intracellular cAMP levels of the 
sperm incubated under capacitating conditions, which suggested a mechanistic role of 
calcineurin in a PKA feedback loop. Moreover, built on the rationale of the significance of 
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Ca2+/CaM signaling, as a part of our work on Chapter 4, we characterized the presence 
and localization of Ca2+ signaling molecules involved in mouse and human sperm. In 
addition, we provided evidence that CaMKII is regulated during capacitation and is 
associated to cAMP/PKA pathway. Taken together, our data provide evidence for the role 
of novel signaling molecules in sperm capacitation. Understanding of the underlying 
mechanisms how these molecules regulate sperm capacitation will provide new insights 
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Spermatogenesis is the process of the production of sperm from primordial germ 
cells (PGCs) in seminiferous tubules of the testes. During this process, PGCs give rise to 
type A1 spermatogonia which are found on the basement membrane of the sex cords21 
After reaching maturity, A1 spermatogonia give rise to A2 type spermatogonia, which then 
gives rise to A3, and A3 to A4 type. During this process each type of spermatogonia has 
the ability to self-renew. The A4 spermatogonium now has three options in the 
development process. It can either self-renew, undergo apoptosis or can differentiate into 
the committed stem cell type, the intermediate spermatogonium. These intermediate 
spermatogonia once committed to produce spermatozoa begin their journey by dividing 
mitotically to produces type B spermatogonia, which then again undergoes another round 
of mitotic cell division to produce primary spermatocytes. Each primary spermatocyte then 
undergoes first meiotic cell division to produce two secondary spermatocytes, which then 
undergoes another round of meiotic division to produce haploid cells known as 
spermatids. At this time, the wave of germ cell differentiation that initiated from the 
basement membrane reaches close to the lumen of the seminiferous tubules. In this 
process, the germ cells are held together by cytoplasmic bridge as they progress towards 
the lumen. Spermatids that are connected to the cytoplasmic bridge after further 




spermatozoa 22. One of the major events that happen during the transitioning of 
spermatids to the sperm cell is the dissociation of nucleosome and replacement of 
histones by protamines, relatively small arginine rich nuclear proteins23. This process 
completely shuts down transcription of genes in the sperm nucleus. Moreover, throughout 
spermatogenesis, germ cells remained bound to the Sertoli cells and ensures that 
developing germ cells are fully nourished and protected (Figure 1-1). 
In humans, spermatogenesis takes about 65 days to complete. In contrast, the 
entire process is completed in 35 days in mice where spermatogonial stage lasts for 8 
days, meiosis lasts for 13 days, and spermiogenesis takes another 13.5 days. In human, 
each day about 100 million sperm are produced in the testicles each day, and about 200 
million spermatozoa are released per ejaculation. In his entire lifetime humans can 
produce about 1012 to 1013 sperm 24. 
1.2  Sperm Epididymal Maturation 
After the completion of spermatogenesis, sperm are fully differentiated and 
morphologically matured. However, they do yet have the ability to fertilize the egg. In 
order for sperm to acquire fertilizing ability, they need to undergo two extra-testicular 
maturation events; one in the male reproductive tract known as epididymal maturation 
(see review25) , which will be discussed here, and in the female tract known as sperm 
capacitation1,26,25,27, which will be discussed in the later topic.  
Epididymis is a highly segmented structure that is divided into three major anatomical 
regions: caput (proximal region close to the testis), corpus (middle portion), and cauda 




gene expression pattern and contains distinct luminal ionic environment suggesting the 
significance of these anatomical structures in sperm maturation25.  
Caput sperm are immotile and are unable to fertilize the egg. As the sperm progress 
from caput to cauda regions of epididymis, sperm undergoes several morphological, 
biochemical and physiological changes that ultimately enable sperm to gain fertilizing 
ability when incubated in a media conducive to capacitation (described in later topics)25. 
Some of the major changes that occurs during sperm epididymal transit are; acquisition 
of sperm progressive motility28, migration of cytoplasmic droplet from sperm neck towards 
the annulus29, changes in the sperm proteome30,31, modification of sperm surface 
proteins32,33 and activation of several signaling pathways30,34,35. 
1.3 Axoneme: The Motility Apparatus of Sperm Flagella  
Radial spoke proteins form a multi-unit protein structure present in eukaryotic cilia 
and flagella 36. Among these structures, the sperm flagellum is typically divided into three 
sections: the mid-piece, the principal piece, and the end piece. These compartments have 
a central axoneme, which is a 9 + 2 structure consisting of a central pair of microtubules 
surrounded by nine peripheral microtubule doublets (Figure 1.2) 37. Schematic diagram 
of mammalian sperm axoneme. Throughout the mid- and principal pieces, the axoneme 
is surrounded by nine outer dense fibers (ODF). However, while the mid-piece ODF are 
wrapped in a helix of mitochondria, the principal piece ODF is covered by a fibrous 
sheath37. In addition to the central pair and outer doublets, the axonemal structure has 
dynein motors and radial spoke proteins 36. Dyneins are minus-ended microtubule motors 




active sliding of the microtubules. Radial spokes connect the central microtubule pair with 
the outer doublets throughout the axoneme and play an essential role in converting the 
dynein-dependent microtubule sliding into flagellar bending. The radial spoke structure is 
composed by at least 23 proteins, which are classified into two subfamilies, following their 
localization in the general spoke structure. Each spoke is T-shaped with an enlarged 
“head” projecting toward the axonemal central pair, and a thinner “stalk” which binds to 
the A microtubule of the outer doublets. Studies using the flagellated algae C. reinhardtii 
provided evidence indicating that radial spoke proteins act as signal transducers that 
control protein phosphorylation and motility 38. In addition, radial spoke defects have been 
shown in human patients presenting primary cilia dyskinesia, a pathology that causes 
respiratory problems and infertility due to immotile cilia and flagella 39–41. 
1.4 Sperm Acrosome Reaction 
To achieve successful fertilization mammalian sperm traverses the cumulus mass 
surrounding the egg, temporarily binds to the zona pellucida, penetrates the peri-vitelline 
space and ultimately fuses with the egg’s plasma membrane 42. However, during this 
process at some point sperm must undergo acrosomal exocytosis and only the sperm 
that are acrosome reacted can fuse with the egg.  “Acrosome” is the golgi-derived 
subcellular organelle located underneath the anterior plasma membrane of sperm head. 
Before fertilization, sperm have an intact acrosome but upon mobilization of internal 
calcium stores through capacitation associated events, sperm plasma membrane fuses 
with the outer acrosomal membrane (Figure 1.3) 42. This fusion process allows the 
release of the acrosomal contents outside of the sperm. But where does the acrosome 




first sperm penetrates the cumulus mass and exocytosis is triggered by sperm binding to 
the zona pellucida. Consistent with this hypothesis, only acrosome reacted sperm were 
observed in peri-vitelline space while acrosome intact sperm were seen floating on the 
surface of the zona pellucida when observed under Electron Microscopy 43. In addition to 
this, solubilized zona pellucida was also able to induce acrosomal exocytosis in vitro 44. 
However, this model is contradicted by the evidence that acrosome intact sperm (Acr-
EGFP) were seen for extended periods of time on the surface of mouse zona pellucida 
during live cell imaging and suggest the alternative hypothesis that fertilizing sperm is 
already acrosome reacted before reaching zona pellucida 45. To study this possibility, 
Inoue et al. using two transgenic mice model that lacked either Izumo I -/- (sperm surface 
protein that cannot fuse with normal eggs) or Cd9-/- (egg plasma membrane that cannot 
fuse with normal sperm) showed that acrosome reacted sperm can penetrate the zona 
pellucida and fertilize egg 46–48. These findings further confirmed the hypothesis proposed 
by Jin et al. that fertilizing sperm undergo acrosomal exocytosis within the cumulus mass 
before encountering the zona pellucida 45. Taken together these several hypothesis, 
Inoue et al. have proposed that acrosomal exocytosis event is not a mandatory event that 
needs to happen in the cumulus mass or during the induction by Zona pellucida, rather it 
is an event dependent on the conditions encountered by sperm during its journey to the 
egg. In the future, it will be intriguing to know what factors or macromolecules are involved 
in these two distinct processes of acrosomal reaction and how each leads to the fusion 
of egg and sperm ultimately leading to fertilization 42. 




Mammalian fertilization is a unique process where two haploid gametes (egg and 
sperm) commits to produce a genetically distinct offspring through sequential 
orchestrated events in the female reproductive tract. During this process, sperm travel 
through viscous environment of female tract, penetrate the egg through cumulus mass, 
binds to the zona pellucida, undergoes acrosomal exocytosis and fuses with eggs plasma 
membrane. However, freshly ejaculated sperm do not have the ability to fertilize egg even 
though are morphologically matured and can move progressively 6. To achieve fertilizing 
ability, sperm needs to reside in the female reproductive tract for a finite period of time. 
During this time sperm undergoes several physiological changes that include 
hyperactivation of sperm tail and preparation of sperm for acrosome reaction (AR) 6. This 
time-dependent acquisition of fertilizing ability of sperm is known as “capacitation”1,2,6. 
Normally, capacitation occurs in the female reproductive tract, nonetheless, it can also be 
achieved in vitro in a defined culture media that contains necessary components of the 
female tract 27.   
1.5.1 Molecular Basis of Sperm Capacitation.  
As soon as sperm comes in contact with isotonic (HCO3- and Ca2+) environment 
of the female tract, it starts a vigorous flagellar movement known as activated sperm 
motility. This early event in capacitation occurs immediately after sperm are exposed to 
HCO3- and Ca2+. At the molecular level, this activated sperm motility is correlated with an 
increase in PKA activity mediated by synergistic stimulation of a unique type of soluble 
adenyl cyclase (sAC) by HCO3- and Ca2+3. Upon stimulation, sAC metabolizes ATP and 
promotes synthesis of cAMP molecules, which then activates protein kinase A (PKA) 




various PKA target proteins in their Ser/Thr residues and initiates activation of several 
signaling pathways 3. However, this initial activation is not sufficient for sperm to achieve 
capacitation. For sperm to achieve capacitation, they need to reside in the female tract 
for an extended period of time 1,2. In vitro, capacitation can be achieved by incubating 
sperm for at least 45 min in a media containing Ca2+, HCO3- and bovine serum albumin 
(BSA) 3. After extended period of incubation in vivo or in vitro, sperm prepares for 
exocytotic acrosome reaction and displays an asymmetric, whip-like motion of the tail 
known as hyperactivation 6. At the molecular level, such changes in the motility pattern 
are correlated with an increase in tyrosine phosphorylation of sperm flagellar proteins 
(Figure 1.4). Hence these late events of capacitation are characterized as slow events3,5. 
1.5.1.1 Soluble Adenylyl Cyclase (sAC)   
 
In mammalian cells, cAMP is synthesized by two types of adenylyl cyclase: G 
protein-regulated transmembrane adenylyl cyclases (tmACs) and HCO3- and Ca2+ -
regulated soluble adenylyl cyclase (sAC). While tmACs are ubiquitously expressed and 
consist of nine family membranes (Adcyl 1-9), sAC is predominantly expressed in male 
germ cells and in other HCO3- responsive tissues 16,49,50. sAC is encoded by a single Adcyl 
10 (also known as sAC, SACY) gene and it is alternatively spliced to give multiple Adcyl 
10 isoforms. Two protein products, a full length 187-kD (sACf) and a proteolytically 
processed 48-kD (sACt) isoforms, have been identified in the cytosolic extracts of rat 
testis and in fractionate homogenates of epididymal sperm. Unlike tmAcs, sAC is 
responsive to HCO3- in the presence of Mg2+ -ATP, a physiological substrate of sAC. 
However, it is insensitive to non-physiological activator like forskolin, G protein and other 




CO2, ATP and Ca2+ 51,52,53.In vitro, activity of sAC is dependent on physiological levels of 
ATP, meaning sAC is less active when there is diminished or elevated ATP levels in the 
cell. However, in the presence of Ca2+, sAC binding affinity towards ATP increases, and 
the enzyme Km for ATP decreases ,making sAC more responsive to the changes in 
HCO3-51. Interestingly, sAC shares a significant sequence homology to adenyl cyclases 
from cyanobacteria which have been reported to be HCO3- dependent 16. This suggests 
that sAC is responsible for the synthesis of cAMP that is associated to capacitation related 
events. Consistently, in mouse sperm cAMP levels peak within a minute of exposure to 
HCO3- which then comes to the basal level over the incubation period. Moreover, a self-
regulatory feedback loop has been purposed where PKA have been shown to regulate 
cAMP synthesis by phosphorylating sAC 54. More details on PKA regulated feedback loop 
will be discussed in Chapter 3.  
To gain more insight into the importance of sAC in capacitation associated events, 
loss of function experiments were performed using both genetic and pharmacological 
approaches. Genetic deletion of sAC in male mice rendered mice infertile. Moreover, 
sperm from sAC knock-out mice were immotile and did not undergo capacitation 
associated tyrosine phosphorylation 55. More importantly, sAC knock-out mice presented 
a significantly reduced levels of cAMP levels when incubated under capacitating condition 
containing HCO3- 56. Consistent with this knock-out model, inhibition of sAC by KH7 (a 
small molecule that competes with Mg2+ ATP for sAC binding) in a sperm incubated under 
capacitating condition blocked cAMP synthesis, protein tyrosine phosphorylation, and 




dependent activation of cAMP/PKA pathway that is necessary to achieve successful 
fertilization event. 
1.5.1.2 Transmembrane Adenylyl Cyclases (tmACs)   
 
In sperm, sAC induces HCO3- dependent synthesis of cAMP and initiates several 
capacitation associated events 3. In contrast, the role and presence of tmACs (Adcyl 1-9) 
in sperm is controversial. tmACs are known to be regulated by stimulatory heterotrimeric 
Gs proteins and are stimulated by diterpene, forksolin and GTP analogs 57. Like in other 
cell types, researches attempted to use forksolin and diterpene to stimulate cAMP 
production in the sperm. Some authors reported no increase in cAMP levels 53,55,58,59while 
some observed forskolin-dependent elevation of cAMP concentration 56,18. However, 
consistent with the later report, our group identified stimulatory subunit Gs in mouse 
sperm and discovered its specific localization in sperm anterior head suggesting its role 
in acrosome reaction. Consistently, when sperm were incubated in conditions that support 
capacitation, forksolin induced a concentration dependent increase in acrosome reacted 
sperm. In agreement with these results, there was elevated levels of cAMP in forksolin-
treated sperm from sAC knock-out mice incubated under capacitating condition56. These 
findings suggest the hypothesis that there is a local production of cAMP by two different 
types of adenyl cyclases for specific purposes; one in the sperm tail for motility and 
hyperactivation function by sAC and other in the head for acrosomal exocytosis by tmACs 
60. Nonetheless, it is unclear how the tmACs associated cAMP is involved in acrosomal 
reaction. Research has shown that GDP/GTP exchanger protein EPAC, one of the targets 




exocytosis 61. However, to understand precise role each of these tmACs, development of 
specific antibodies and pharmacological inhibitors is still necessary.  
1.5.1.3 Phosphodiesterases (PDEs)  
cAMP regulates several signaling pathways in the cell. In accordance to the time 
and need its levels are tightly regulated by adenyl cyclases (AC) and cAMP 
phosphodiesterase (PDE). As mentioned above, AC synthesizes cAMP from ATP and 
PDE hydrolyzes the phosphodiester bond of cAMP to produce 5’-adenosine 
monophosphate (AMP) 62,63. In mammals, there are 11 families of PDE encoded by more 
than 20 genes. Considering all the isoforms from 20 genes, there could be more than 100 
PDEs that could either hydrolyze either cAMP, (PDE4, PDE7, and PDE8) cGMP (PDE5, 
PDE6, and PDE9) or both (PDE1, PDE2, PDE3, PDE10, and PDE11 17. In mouse sperm, 
only PDE1, PDE3, PDE6, PDE8 were detected at mRNA level. However, specific 
antibodies detected the presence and localization of PDE1, PDE4, PDE6, PDE8, PDE10, 
PDE11 in sperm lysates as well as in the intact sperm cells 64. Of these PDEs, PDE1 
(inhibited by MMPX) and PDE4 (inhibited rolipram) have been shown to increase 
intracellular cAMP levels when inhibited by their selective inhibitors in both mouse and 
human sperm 64. However, the localization and role of these two PDEs have been 
controversial in different species. Wasco and Orr first reported PDE1 as Ca2+- calmodulin 
dependent PDE and showed its association in the head and tail pieces of rat epididymal 
sperm 19. In mouse sperm PDE1 was exclusively localized in the sperm principal piece 
while PDE4 was localized in both the head and in the flagellum. Furthermore, inhibition 
of PDE4 by rolipram not PDE1 by MMPX induced capacitation and in vitro fertilization 




rolipram) enhanced sperm motility but did not affect acrosomal reaction. On the contrary, 
selective inhibitors of PDE1 only stimulated sperm acrosome reaction 65. Altogether, 
these studies suggest that PDEs are distributed in different compartments of sperm 
(flagellum and head) consistently where adenyl acylases (sAC and tmACs) and 
stimulatory heterotrimeric Gs proteins are also localized and suggest the hypothesis that 
there is a local synthesis and degradation of cAMP molecules in different sperm 
microdomains that are regulated independently56. In support of thesis hypothesis, it has 
been suggested that anchor protein kinases (AKAPs) are involved not only in tethering 
PKA but also PDEs in preventing the diffusion of cAMP into other sperm compartments66. 
 
1.5.1.4 Significance of PKA Signaling in Sperm Capacitation 
Protein kinase A (PKA), also known as cAMP-dependent protein kinase is the best 
characterized target of cAMP 67. It is a heterotrimeric kinase composed of two catalytic 
subunits (C) and two regulatory subunits (R). When PKA is inactive, catalytic subunits 
remain bound to regulatory subunits. However, cAMP binding to regulatory subunits 
triggers the dissociation of catalytic subunit from R subunit and renders the kinase active. 
In mammals, four R subunits genes (RIα, RIβ, RIIα and RIIβ) and five C subunit genes 
(PRKACA, PRKACB, PRKACG, PRKX, and PRKY) have been reported. Expression of C 
genes gives further rise to other C isoforms including Cα and Cβ 68,69. While Cα has only 
two isoforms, Cα1 and Cα2, Cβ gives rise to ten more variants. In the case of the R 
subunit, expression of RIα mRNA was reported in all stages of spermatogenesis while 
RIIα expression was limited to the later stages of development. Interestingly, Cα1 




development and is replaced by Cα2 isoform during meiotic division. Consistently, Cα2 
mRNA was also observed in pachytene spermatocytes and in round spermatids. Thus, 
the expression of regulatory subunit RIIα and catalytic subunit Cα2 of PKA in later stages 
of development during spermatogenesis suggested an important role in sperm function 
(for review see 60).  
Consistently, as soon as sperm comes in contact with Ca2+ and HCO3- in the 
seminal plasma, cAMP levels rapidly rises, which then leads to the activation of PKA. It 
has been suggested that sAC is the adenyl cyclase that is involved in HCO3- dependent 
increase in cAMP levels and subsequent activation of PKA 3. This hypothesis is further 
bolstered by the lack of effect of forskolin on PKA activation 50, along with the presence 
of stimulatory heterotrimeric (Gαs) proteins on sperm anterior head 56, and the precise 
localization of PKA catalytic subunit in the sperm flagellum 70. Once activated, PKA then 
phosphorylates various target proteins and triggers the activation of several signaling 
pathways. Using antibodies that specifically recognizes the substrates phosphorylated by 
PKA, it was reported that PKA activity increases within a minute of HCO3- exposure in 
different species 71–73. This fast event of PKA activation has been correlated to initiation 
of vigorous sperm motility also known as activated motility. At this time, even though 
sperm move vigorously, they do not fully achieve capacitation and are unable to fertilize 
the egg. To achieve capacitation, as mentioned above sperm requires an extended period 
of incubation (also known as late events) in a defined media that contains Ca2+, HCO3-, 
and BSA. As in the early events of capacitation HCO3- and Ca2+ are involved in the 
stimulation of sAC, followed by cAMP increase and subsequent PKA activation 3. The 




that it functions as a sink for the depletion of sperm plasma membrane cholesterol 3. After 
extended period of stay in the female tract or extended incubation period in vitro, sperm 
prepares for acrosomal reaction and displays a powerful, asymmetric, whip-like motion of 
the tail known as hyperactivation 1,2,6. At the molecular level such changes in sperm 
motility pattern are associated with increase in tyrosine phosphorylation of sperm flagellar 
proteins 5. Since these late events of capacitation require extended period of incubation, 
it can be inferred that the PKA action on this pathway is not direct, rather it is due to 
downstream activation of PKA signaling cascades 3.  
The role of PKA in sperm capacitation was studied using both genetic and 
pharmacological approaches. Inhibition of PKA by a battery of inhibitors such as H-89, 
Rp-cAMPS, and PKI inhibited PKA activity, as well as downstream increase in 
phosphorylation of protein tyrosine phosphorylation and hyperactivated sperm motility. 
Consistently, inhibition of PKA activity completely blocked the ability to fertilize the egg in 
in vitro fertilization assay 73,74. To further confirm pharmacological approaches, these 
results were validated using genetic knock-out mouse model. Although genetic deletion 
of Cα1 produced infertile sperm, its deletion caused several other defects that made it 
difficult to accurately assess reproductive phenotype 75. Considering the sperm-specific 
expression of Cα2, genetic deletion was made using homologous recombination method 
in unique N -terminus region of Cα2 gene. Deletion of Cα2 gene produced a mouse model 
that displayed only a reproductive phenotype. Even though Cα2 null mice produced a 
normal number of sperm, they did not undergo the capacitation-associated increase in 
tyrosine phosphorylation. Consistently, Cα2 null mice were infertile despite normal mating 





1.5.1.5 Role of Anchor Kinase Proteins (AKAPs) in PKA Signaling 
 
 
PKA is a broad specificity Ser/Thr kinase known to activate several signaling 
pathways associated to metabolism, memory, exocytosis, motility, and many others 66. 
As mentioned above, during capacitation PKA activates distinct signaling pathways; some 
are early and fast events, and some are late and slow events 3. But how PKA 
discriminately phosphorylates its targets in accordance to time and need during 
capacitation has been a topic of interest for so many years.  
Anchor kinase proteins (AKAPs) are a family of proteins that are known to bind to 
the regulatory subunit (RII) of PKA and have been implicated in the regulated PKA 
signaling thereby confining its activity in discrete locations in the cell 66,76. Two sperm 
specific anchor proteins, AKAP3 and AKAP4, have been reported to bind with PKA RII 
subunits and have been shown to localize throughout sperm flagellum 77–79. Interestingly, 
both of these proteins are also phosphorylated during capacitation, however the link 
between AKAP phosphorylation and capacitation is not well understood80,81,7,9,14. Role of 
AKAPs in sperm physiology was studied with both genetic and pharmacological 
approaches. Disruption of AKAPs binding to PKA RII subunit by a membrane-permeable 
stearated form of peptide Ht-3, St-Ht31 impaired sperm motility and onset of capacitation 
associated events 74,82. Consistently, sperm lacking functional AKAP4 were infertile and 
presented and morphological defects in flagella possibly due to the loss or delocalization 
of fibrous sheath proteins. Interestingly, there was no alteration in cytoskeleton structures 





1.5.1.6 Significance of Tyrosine Phosphorylation in Sperm Capacitation  
 
 
During epididymal maturation, even though sperm acquire progressive motility 
they cannot fertilize egg. Sperm achieve their fertilizing competency in the female tract by 
undergoing a series of biochemical and physiological changes 1,2,3. At the molecular level, 
these changes are associated to HCO3- dependent fast activation of cAMP/PKA pathway 
mediated through sAC. Activation of this pathway initiates phosphorylation of several PKA 
substrates, which then triggers activation of downstream signaling cascades ultimately 
leading to the phosphorylation of tyrosine residues of several proteins 3–5. This increase 
in tyrosine phosphorylation has been correlated with the change in sperm motility pattern 
from activated to hyperactivated motility pattern and has been understood as an end point 
of capacitation in many species 84,85,7. Moreover, it has been reported that tyrosine 
phosphorylation is a downstream event of cAMP/PKA pathway. Pharmacological 
inhibition or the genetic deletion of upstream players such as sAC or PKA, or the omission 
of any of the factors responsible for activation of cAMP/PKA pathway (HCO3-, Ca2+), 
results in the inhibition of capacitation associated protein tyrosine phosphorylation 4,5,55. 
Consistently, sperm fails to hyperactive and cannot fertilize egg in vitro as well as in vivo. 
Nonetheless, the identity of the tyrosine kinase responsible for activation of this signaling 
cascade is not fully understood. Based on the pharmacological and immunological 
evidences, a list of potential tyrosine kinases were considered. Some of the most relevant 
ones were c-Src 73,86, FYN 87, ABL88 and both members of the focal adhesion kinase 
(FAK) family, FAK and proline-rich tyrosine kinase 2 (PYK2)88,89.  
In an effort to investigate the role of c-Src in capacitation associated increase in 




SU6656 blocked capacitation associated increase in tyrosine phosphorylation. However, 
c-Src family kinase inhibitors also blocked PKA substrate phosphorylation, sperm motility, 
and in vitro fertilization suggesting inhibition of increase in tyrosine kinase 
phosphorylation may be due to inhibition of PKA substrate phosphorylation. Interestingly, 
all of this capacitation associated parameters were recovered when sperm were 
incubated with the inhibitors of Ser/Threonine inhibitors such as okadaic acid and 
calyculin-A 73. These findings suggested that Src is not directly involved in the 
capacitation-associated increase in protein tyrosine phosphorylation. Rather, it is involved 
in the inactivation of Ser/Thr phosphatases by phosphorylation and thus preventing the 
dephosphorylation of PKA substrates. Overall, our study provided the strong evidence 
that capacitation is regulated by two parallel process: one by activation of PKA and a 
second one by inactivation of Ser/Thr phosphatases.  
Furthermore, our quest to find the tyrosine kinase responsible for capacitation 
associated increase in tyrosine phosphorylation continued with the investigation of 
members of focal adhesion kinases FAK1 and PYK2. Even though it was reported that in 
human and stallion sperm, inhibition of FAK1 and PYK2 blocked increase in tyrosine 
phosphorylation 90, our group further validated these data in mouse sperm with both 
genetic and pharmacological approaches. Consistent with previous findings, inhibition of 
PYK2 by PF431396 blocked capacitation associated tyrosine phosphorylation. However, 
sperm from pyk2-/- mouse displayed normal increase in tyrosine phosphorylation 
suggesting PYK2 is not involved in this phosphorylation process of capacitation 91. Since 
PF431396 can also block FER, a known tyrosine kinase present in sperm, and has been 




in this process. Inhibition of FER by PF431396 blocked the activity of FER in vitro kinase 
assay. As expected, sperm from mice that lacked a functional Fer gene failed to undergo 
capacitation associated-increase in tyrosine phosphorylation. However, to our surprise, 
fertilization was normal in vivo, even though sperm from these mice displayed reduced 
ability to fertilize egg in vitro 91. Our study challenged the long-standing paradigm of the 
necessity of increase in tyrosine phosphorylation as a requirement for fertilization. 
However, we cannot discard the possibility that factors in the female reproductive tract 
present during the course of natural mating could have compensated for the lack of 
FER91.  
 
1.6 Classification of Ser/Thr phosphatases  
Even though it is understood that regulation of cellular process requires a 
coordinated action of protein kinases and protein phosphatases, relatively less 
information is available on phosphatases. Based on the nature of dephosphorylation from 
particular amino acid residues, protein phosphatases (PPs) are classified into two 
categories: protein tyrosine phosphatases (PTP) and Ser/Thr phosphatases (PSPs). 
Compared to protein kinases (90 tyrosine kinases (PTKs) and 428 serine/threonine 
kinases (Ser/Thr)) 92,93, abundance of protein phosphatases (PTP; 107 and PSP; 30) is 
relatively low in the human genome 94,95. For high specificity and reversible nature of 
phosphorylation, a kinase-to-phosphatase ratio should be similar. Even though this 
hypothesis holds true for PTKs and PTPs, PSPs number is relatively low to regulate such 




PSPs can form combinations of PSP holoenzymes by sharing a catalytic subunit to a 
large number of regulatory subunits 94. 
In 1983, Ingebrigtsen and Cohen pioneered classification of available Ser/Thr 
phosphatases in the literature. The group suggested that most of the activities of 
phosphatases can be explained by two types of protein phosphatases. Based on the 
substrate specificity, biochemical structures, sensitivity to their endogenous and specific 
inhibitors, mammalian phosphatases are divided into two major subtypes: PP1 and PP2. 
PP2 is further divided into PP2A, PP2B, and PP2C 96. PP1 is regulated by two 
endogenous inhibitory proteins I-1 and I-2. Interestingly, despite high sequence 
conservation, PP2A and PP2B are insensitive to I-1 and I-2, which was considered the 
major basis of classification between PP1 and PP2 phosphatases 96. Within the PP2 
family also, PP2A does not require divalent cations for activation and is inhibited by two 
potent inhibitors; Calyculin A (CL-A) and Okadaic Acid (OA) at nano-molar concentration 
97. PP2B, also known as calcineurin is activated only in the presence of Ca2+/ Calmodulin 
(Ca2+/CaM) and is less responsive to OA and CL-A (>2μM) 98. PP1, PP2A, PP2B share 
high sequence similarity and are structurally similar, while PP2C is structurally different 
and it is placed on a separate gene family. Moreover, PP2C is highly resistant towards 
inhibition by OA and CL-A. Today, based on sequence homology, PSPs are classified 
into three major families: phospho protein phosphatase (PPPs), metal dependent 
phosphatases (PPMs) and FCP transcription-factor-IIF-associating C-terminal domain 
protein phosphatases 94. PPPs family members include protein phosphatase 1(PP1), 
PP2A, PP2B, PP4, PP5, PP6, and PP794. Similarly, PPM family members include PP2C 




such as Mg2+ and Mn2+. In contrast to all the Ser/Thr phosphatases, FCP/SCP family rely 
on aspartic acid and its only primary target is the CTD of RNA polymerase II94. As 
mentioned above, catalytic subunit of the most members of PPPs associate with a variety 
of regulatory subunits and forms a unique holoenzyme for distinct substrate specificity. 
However, PPM members lack regulatory subunits but contain unique domains and 
conserved sequence motifs in their sequence which determines their substrate 
specificity94. 
 
 1.6.1 Role of PP1 in Epididymal Sperm Maturation 
In mammals, four isoforms of catalytic subunit of PP1 are identified; PP1, PP1, 
PP11, and PP2 99. While PP1, PP1, PP11 are ubiquitously expressed, PP2 is 
reported to be present only in testis and sperm of many species such as mouse, human, 
hamster, and bull 35. In the testis, PP2 is localized in the post-meiotic cells, secondary 
spermatocytes and round spermatids, and is completely absent in early spermatogonia, 
pachytene spermatocytes, and interstitial cells.99 Genetic knock-out of PP1 are infertile 
due to defect in spermatogenesis. Solar et al. demonstrated the importance of PP2 by 
expressing transgenic PP2 in the genetic knock-out phenotype of PP1 mice. Transgenic 
expression of PP2 in these mice restored normal development and viability of spermatids 
and spermination but did not restore normal spermatogenesis 100. This suggested that 
PP2 is important for germ cells development and not for spermatogenesis.  
The role of PP1 in sperm motility and function was demonstrated by the group of 
Vijayaraghavan and colleagues. Using bovine sperm, the authors identified PP1 and its 




cytoplasmic form of PPP1I. However, this inhibition can be overcome by the addition of 
purified glycogen synthase kinase-3 (GSK3) in vitro 35 . Therefore, GSK3 was proposed 
as an endogenous modulator of PP1. In bovine sperm, immotile caput sperm contained 
higher levels of PP1 (twofold) and GSK3 (sixfold) activities compared to motile cauda 
sperm suggesting a hypothesis that both PP1 and GSK3 play a role to ensure sperm in 
immotile state 35. Consistently, when authors inhibited PP1 with OA or CL-A at micro and 
nano-molar concentrations, they were able to induce motility in caput sperm similar to the 
levels observed in cauda sperm. This suggested that PP1 is involved in epididymal 
maturation of sperm 35. In addition to PP1, PP2A was also identified in mouse, human, 
bovine and fowl sperm and has been shown to a play an important role in sperm motility 
and capacitation (for review see 101). Discussion of Ca2+/CaM dependent phosphatase 
PP2B will be discussed in Chapter 3.  
 
1.6.2 Involvement of PP1 and PP2A in sperm capacitation   
Sperm are transcriptionally and translationally silent. Most of the cellular processes 
in sperm are carried out by post-transcriptional modifications, mainly phosphorylation 102. 
As described above, sperm capacitation involves sequential phosphorylation events of 
Ser/Thr and Tyr residues of many sperm proteins. It is now well established that PKA is 
the Ser/Thr kinase that is implicated in phosphorylation of sperm proteins associated to 
capacitation 3. Moreover, it is in general consensus that this phosphorylation event also 
requires participation of Ser/Thr phosphatases. But the identity of the Ser/Thr 
phosphatases and their involvement in capacitation associated events is not well 




and sperm capacitation came from the group of Furuya and colleagues103. In this work, 
authors evaluated the effect of Ser/Thr phosphatases inhibitors; OA, and CL-A on 
capacitation process using the chlortetracycline (CTC) fluorescent assay. Their results 
showed that OA and CL-A induced a rapid appearance of B pattern, a method to monitor 
capacitation process. Similarly, group of Goto and Harayma also investigated the effect 
of calyculin A (PP1/PP2A inhibitor) on sperm capacitation 104. Instead looking at B pattern, 
this group used an antibody directed against phosphorylated PKA substrates that 
recognize either RXXpS/pT or RRXpS/pT consensus site to monitor PKA activity. Finding 
of their result not only showed increased PKA phosphorylation when sperm were 
incubated with CL-A in capacitating condition, but also increased percentages of 
hyperactivated sperm. Similarly, previous work from our lab has demonstrated that 
inhibition of Src kinase inhibits PKA substrate phosphorylation, sperm motility and in vitro 
fertilization but these effects are overcome when sperm were incubated with OA and CL-
A at concentration reported to affect only PP2A 73.  
 
1.7 Significance of Ca2+ signaling in Sperm Capacitation 
1.7.1 CatSper: A Principal Ca2+ Channel in Sperm 
Intracellular calcium ion concentration ([Ca2+]) regulate several physiological 
processes in mammalian sperm. Some of these processes are sperm hyperactivation, 
capacitation and acrosome reaction. Even though prototypical voltage-gated Ca2+ 
channels have been reported to be present in sperm, their presence in other tissues had 
made it extremely difficult to distinguish between the Ca2+ ion channels important for 




channel of SPERm) has provided a novel tool to investigate the role of Ca2+/ 
Ca2+channels in sperm physiology 105.  
CatSper is a sophisticated complex structure composed of 9 different subunits; 
four α-subunits (CatSper1-4 forms pore forming structure) and five other additional 
auxiliary subunits CatSper β,  δ, , ζ (see for review 106) . CatSper 1 was identified and 
cloned in 2001 during bioinformatic search for the genes that have similar sequences to 
voltage-gated calcium channels 107. CatSper  and ζ are the recently identified CatSper 
subunits106. Immunolocalization experiments validated that CatSper subunits are 
exclusively expressed in testis and precisely localized to the principal piece of sperm 
flagella 14,108. These results were further confirmed by the detection of CatSper (ICatSper) 
current by patch-clamp electrophysiological method. This method precisely and 
reproducibly measured CatSper currents only in sperm fragments containing the principal 
piece and midpiece and not from the fragments consisting the head and midpiece 105,108. 
Since then this method has been widely used to detect CatSper current in other species 
including human and macaque. Experiments from mice and human models have 
conclusively demonstrated that CatSper facilitates Ca2+ entry into the sperm tail and is 
the only principal Ca2+ channel required to switch the symmetrical progressive motility of 
sperm to hyperactivated motility105. Male mice lacking any of the CatSper gene (1-4) or δ 
are unable to hyperactive and therefore fails to penetrate the egg’s protective vestments 
and thus are infertile. It has been reported that deletion of CatSper 1 results in complete 
loss of expression of CatSper 2, 3 4, β,  and δ subunits, and deletion of CatSper δ results 




auxiliary subunits are expressed and function in a coordinated manner to form a functional 
CatSper channel.  
 
1.7.2 Regulation of CatSper Channel 
 
In both mouse and human sperm, HCO3- entry via Na+/ HCO3- co-transporter 
activates sAC which then increases cAMP levels and activates PKA 3. Increased PKA 
activity has been linked to an increase in intracellular pH 109. This intracellular alkalization 
has been shown to activate CatSper channel leading to Ca2+ entry into the sperm tail 
107,108. Even though capacitation is associated to an increase in intracellular Ca2+ levels, 
a role of cAMP in this process has been controversial. In human sperm, progesterone 
produced by cumulus cells can also stimulate CatSper channel by a non-genomic 
mechanism 59. However, CatSper is insensitive to progesterone in mice suggesting 
species-specific mechanisms of CatSper activation in the female reproductive tract 110. 
For regulated Ca2+ signaling, CatSper channel complex have been shown to work in 
association with other sperm channels such as Ca2+ ATPase 4 pump (PMCA4), sperm 
specific K+ channel (SLO3) and Voltage-gated H+ channel 1 (Hv1). PMCA4 balances 
intracellular Ca2+ through Ca2+ extrusion and acidifies intracellular environment through 
proton intrusion. The resulting acidification is regulated by extrusion of proton via Hv1 
channel. Similarly, SLO3, a pH sensitive K+ channel hyperpolarizes sperm flagellar 
membrane potential during sperm capacitation and facilitates Ca2+ entry through the 
CatSper channel 111. Nonetheless, the molecular mechanism(s) explaining how CatSper 






1.7.3 Organization of Ca2+ signaling domains by CatSper Channel  
To gain insight into this process, Chung et al. used stochastic optical 
reconstruction microscopy (STORM) to determine three-dimensional distribution of sperm 
flagellar proteins within a single flagellum 14. They showed that CatSper is distributed in 
a quadrilateral arrangement in three dimensions, where each structural unit organizes 
structurally distinct Ca2+ signaling domains along the length of the principal piece of sperm 
flagellum. Signaling molecules that are reported to form these Ca2+ domains are: 
calmodulin-dependent kinase II (CaMKII), testis specific catalytic subunit of calcineurin 
(protein phosphatase 2B; PP2B-A), and scaffolding protein of cholesterol rich domain, 
Caveolin 1 14. Using a genetic knock-out model, authors showed that disruption of 
CatSper1 disrupts the localization of constitutively active phosphorylated form of CaMKII 
(pThr286), PP2B-A, and Caveolin 1. Moreover, using Caveolin null mice, the authors 
demonstrated that CatSper but not Caveolin 1 is responsible for organizing Ca2+ domains 
in mouse sperm. Moreover, consistent with the role of CatSper in sperm hyperactivation 
and this hyperactivated sperm motility is associated with tyrosine phosphorylation (P-Tyr) 
of sperm axonemal protein, deletion of CatSper resulted in aberrant and premature P-
Tyr. It was reported that in WT mice P-Tyr was precisely confined in the axonemal region 
and occurred in a timely fashion, while P-Tyr signal dissipated from center of axoneme to 
the peri-axoneme and the phosphorylation events occurred much faster in the CatSper 
null mice 14. This suggests that CatSper organizes Ca2+ signaling domains, regulates 
downstream signaling through focused P-Tyr in sperm axoneme and initiates 





1.7.4 Role of Ca2+/CaM (Calmodulin) in sperm capacitation  
Calmodulin (CaM) is an evolutionary conserved, ubiquitously expressed Ca2+ 
sensor protein. Ca2+ binding to CaM activates Ca2+/CaM complex, which then binds to 
Ca2+/CaM dependent targets and regulates several signaling processes 112. More 
importantly, phosphorylation of CaM on tyrosine (Y) residue at position Y100 by various 
cellular protein kinases has been suggested to initiate activation of additional signaling 
cascades. Corti et al. demonstrated that phosphorylation of CaM at this residue enhances 
activation of six important target enzymes; myosin light chain kinase (MLCK), PDE, 
PMCA, CaMKII, PP2B, and nitric oxide synthase (NOS) 10. Of these CaM targets, PDE 
degrades cAMP and regulates its levels during sperm capacitation. A detailed discussion 
on PDEs is described above. Role of other CaM targets; PP2B and CaMKII will be 
discussed in Chapter 3 and Chapter 4 respectively.  
Interestingly, a phosphoproteomics analysis revealed that this particular peptide 
sequence (DGNGY*ISAAELR; Y100) that belongs to CaM is highly phosphorylated on 
tyrosine residue during sperm capacitation and this peptide was even more 
phosphorylated in CatSper null mice 14. These results were further confirmed by western 
blot analysis using P-CaM Y100 antibody 14. Moreover, our group used pharmacological 
inhibitors of CaM (Calmidazolium and W7) and investigated its role in protein tyrosine 
phosphorylation in the WT sperm incubated under capacitating media devoid of Ca2+. 
Capacitating condition without added Ca2+ in the presence of CaM inhibitors mimicked 
CatSper null sperm incubated in normal capacitating media. Consistent with the previous 




suggesting its critical role in sperm motility and hyperactivation 113. Nonetheless, a 
complete mechanism of how CaM regulates cAMP/PKA pathway and the role of its 
downstream target in this process is still a work in progress. 
 
1.7.4.1 Ca2+/CaM-dependent Ser/Thr phosphatase (Calcineurin) 
Calcineurin (PP2B) is a Ca2+/CaM dependent Ser/Thr phosphatase involved in 
regulation of several biological processes such as neurodevelopment and memory, 
immune response, signal transduction and many more 114. Calcineurin is composed of a 
catalytic subunit and a regulatory subunit also known as calcineurin A (CAN) and 
calcineurin B (CNB). Catalytic subunit contains N-terminal phosphatase domain, CNB-
binding helix (BBH), an autoinhibitory element, and two catalytic metal ions 94. In an 
inactive state an autoinhibitory  helix loop of CNA associates with phosphate domain via 
hydrogen and van der Waals bonds and blocks access to the calcineurin substrates115 . 
Similarly, the regulatory subunit consists of pair of Ca2+ binding domains where each 
domain forms two EF-hand motifs and are organized around CNB-binding helix. It is 
hypothesized that upon Ca2+/CaM binding to CNB, Ca2+/CaM/calcineurin complex 
undergoes a conformational change which triggers the displacement of an autoinhibitory 
element from the catalytic center of phosphate domain allowing calcineurin access to 
target substrates 94.  
One of the well-known substrates of calcineurin is nuclear factor activated T cells 
(NFAT) 114,116. Structural analysis has revealed that calcineurin can recognize and 
dephosphorylate any protein substrates that contain PxIxIT consensus motif (P, Proline; 




containing this motif has been shown to bind to a surface grove on CNA subunit of 
calcineurin through β- augmentation. Since calcineurin and PP1 are structurally similar, 
PP1 also assumes a similar peptide substrate binding in its catalytic subunit grove. The 
consensus sequence binding motif for PP1 was identified as RVxF (R; Arganine, V, 
Valine; x, any amino acid residue, F; phenylalanine)119. 
In immune cells, calcineurin has been shown to activate T cells by 
dephosphorylating the transcription factor NFAT in which dephosphorylated NFAT 
translocates to the nucleus and induces the expression of interlukin-2 (IL2) 114,116. 
However, this process can be suppressed by two potent calcineurin inhibitors: 
Cyclosporin A (CsA) and FK506, in the presence of their respective cytoplasmic 
immunophilin proteins: cyclophilin A (CyPA) and FKBP12. Despite the lack of structural 
homology, complex of FKBP12-FK506 115,120 or CyPA-CsA 121,122 binds to the composite 
surface formed by CNB and BBH. In this process, both FK506 and CsA make direct 
contact with amino acid residues from CNB, which clearly explains the mechanism by 
which immunophilins require immunosuppressants to bind to calcineurin. This binding 
allows FKBP12 or CyPA to directly associate with the residues of the phosphatase 
domain and CNB-BBH composite surface domain. It has been reported that about 80% 
of interface residues of calcineurin interacts with FKBP12-FK506 (or CyPA-CsA) complex 
123.  Moreover, what determines these immune complexes unique in terms of 
immunosuppressant specific phenotype is the differences in hydrogen bonding with 
calcineurin residues 124,125. For example, interaction of tyrosine 341 (Y341) hydroxyl group 
of calcineurin with CsA via two hydrogen bonds has been reported to be important for 




exist for only CsA and not for FK506. Consistently, mutation of Y341 to phenylalanine 
(Y341F) rendered T cells resistant to CsA but not to FK506124,125 . A detailed mechanism 
on how immunophilin-immunosuppressant complex inhibits phosphatase activity of 
calcineurin is yet to be understood. However, it has been hypothesized that binding of 
FKBP12-FK506 or CyPA-CsA to composite surface that involves BBH domain blocks the 
ability of Ca2+/CaM to activate phosphate domain of calcineurin 94.  
As previously described, calcineurin exists as a heterodimer consisting of catalytic 
and regulatory subunit. In mammals, three isoforms of catalytic subunit: PPP3CA, 
PP3CB, and PP3CC and two isoforms of regulatory subunit: PPP3R1 and PPP3R2 have 
been identified. Isoforms of catalytic subunit encoded by the gene ppp3cc and isoform of 
regulatory subunit ppp3r2 have been shown to be present only in the testis while the 
expression of ppp3ca, ppp3cb and ppp3r1 is ubiquitous 126. Thus, the PPP3CC-PPP3R2 
complex has been reported as sperm specific calcineurin 127. In mouse sperm, calcineurin 
has been shown to confer midpiece flexibility during epididymal maturation, and genetic 
deletion of the testis-specific calcineurin leads to infertility in mice 127 . Furthermore, in 
vitro treatment of sperm with calcineurin inhibitors have been reported to impair sperm 
motility and acrosome reaction 128. While there are few studies on PP1 and PP2A related 
to their role in sperm capacitation, involvement of calcineurin in this process is largely 
unknown.  
1.7.4.2 Ca2+/CaM-dependent Ser/Thr Kinase II (CaMKII) 
CaMKII is a multifunctional Ser/Thr kinase involved in several biological process 
such as cell apoptosis, memory and cardiac ion channel function. It exists as a 




kinase domain, a regulatory domain, a variable linker domain, and a C-terminal 
association domain 129. The association domain forms the central hub and assembles the 
monomers into a dodecamer where pair of monomers are stacked to form a hexameric 
ring. The variable linker domain, as the name suggests undergoes alternative splicing 
and gives rise to four homologous CaMKII isoforms ,β,, and δ that are encoded by 
separate genes 129. In its inactive state, the regulatory subunit remains bound to the 
catalytic subunit and prevents the binding of ATP and substrates 130. Upon Ca2+/CaM 
binding to the regulatory subunit, the enzyme undergoes a conformational change and 
autophosphorylates threonine residue (Thr) at position 286 (Thr286) 131. However, this 
autophosphorylation requires binding of two molecules of Ca2+/CaM to two neighboring 
CaMKII subunits where one subunit is activated as kinase domain and other is activated 
to expose Thr286 for phosphorylation 132. Once phosphorylated at Thr286, CaMKII is 
autonomously activated independent of Ca2+/CaM. Activated CaMKII has much more 
affinity for Ca2+/CaM and its activity is significantly enhanced upon further stimulation by 
Ca2+/CaM129. Moreover, autonomous activity of CaMKII has been shown to be important 
for learning and memory function in the brain. Besides autophosphorylation, autonomous 
activity of CaMKII can also be achieved by oxidation of a pair of methionine residues 
within the CamKII regulatory domain. However, this process also requires initial stimulus 
of Ca2+/CaM 133. Altogether, this suggest that CaMKII activity is regulated by two upstream 
molecules; one Ca2+/CaM and the reactive oxygen species. 
 




Similar to CaMKII, CaMKIV is also a multifunctional Ser/Thr kinases. It is highly 
abundant in nucleus and regulates events that are associated to nuclear function 134,135. 
Upon binding of Ca2+/CaM to its autoregulatory domain, intramolecular inhibition of the 
enzyme is relieved leading to activation of basal kinase activity 136. However, the 
Ca2+/CaM-CaMKIV complex exhibit low kinase activity in vitro and it has been 
demonstrated that it requires phosphorylation by another upstream kinase also known as 
Ca2+/CaM-dependent kinase kinase (CaMKK) 136. CaMKK phosphorylates on the 
activation loop of Ca2+/CaM-CaMKIV complex on threonine residue; mouse Thr 196 and 
human Thr200 137,138. Phosphorylation at this site fully activates CaMKIV, which becomes 
autonomous and no longer requires bound Ca2+/CaM. The fully activated autonomous 
CaMKIV is then able to phosphorylate its target proteins 139. One of the well-studied 
targets of CaMKIV is the transcription factor cAMP response element-binding protein-
mediated transcription (CREB) 140. In addition to this, it has been hypothesized that PP2A, 
Ser/Thr phosphatase physically associates with CaMKIV and negatively regulates its 
activity 141. 
 
The 42Kb genome of Camk4 gene harbors three promoter regions. Transcription 
of first two promoters give rise to two CAMKIV isoforms: α and β, while third promoter 
located on the 10th intron position of Camk4 genome gives rise to calspermin, a 
Ca2+/CaM-dependent protein 134,142. Of these three CaMKIV isoforms, α is ubiquitously 
expressed, β is predominantly expressed in the brain and absent in the testis, and 
calspermin is exclusively expressed in the testis 143. In mouse testis, expression of 
CaMKIV is stage dependent and coordinated with the expression of calspermin. 




in round spermatids, while the expression of calspermin is restricted to pachytene 
spermatocytes 144. Moreover, both northern blot and western blot analysis showed 
increased mRNA and protein levels of CaMKIV as early as day 27 of post-natal 
development and protein levels further increased and reached maximum at day 38. 
Consistently, mRNA and protein levels of calspermin were observed in the same manner 
as CaMKIV suggesting both proteins are expressed in a coordinated manner144. In 
addition, it was reported that CaMKIV is associated with condensing chromatin of 
spermatids and seems to be hyperphosphorylated in detergent insoluble fraction of 
mouse testis suggesting its role in chromatin remodeling 144.  
 Beside predicted role of CaMKIV in nuclear condensation, role of CaMKIV and 
calspermin is unknown. In testis, CaMKIV has been suggested to regulate calspermin 
expression by phosphorylating testis specific CREMt, as calspermin contains cAMP-
responsive elements for CREMt binding in its promoter region for transcription 145. Unlike 
CaMKIV, calspermin lacks kinase activity and has been known to regulate calmodulin 
levels in the cell 143.   
 
1.7.4.4 Role of CaMKII and CaMKIV in sperm capacitation 
It has been demonstrated that the role of Ca2+ during sperm capacitation is 
biphasic113. In normal capacitating conditions, Ca2+ activates sAC, synthesizes cAMP, 
and activates PKA. Activation of cAMP/PKA phosphorylates several PKA substrates 
which then initiates activation of downstream signaling pathway resulting in increased P-
Tyr of several sperm axonemal proteins3–5. During this process, Ca2+ also controls cAMP 




collected and capacitated in a media that lacked Ca2+, activation of cAMP/PKA pathway 
was compromised and sperm failed to hyperactive. Interestingly, when sperm were 
capacitated in a media devoid of Ca2+ containing EGTA (complete chelation of Ca2+), 
phosphorylation of PKA substrates and P-Tyr significantly increased compared to the 
sperm incubated under normal capacitating condition113. In agreement with these results, 
sperm from CatSper null mouse incubated under normal capacitating conditions also 
displayed increased/aberrant P-Tyr than the wild type counterpart14. These findings 
suggest that sperm capacitation is regulated by activation of two parallel pathways; 
cAMP/PKA and Ca2+/CaM pathways. Given the fact that CaMKII and CaMKIV are two 
Ca2+/CaM-dependent kinases and inhibition of CaM by pharmacological inhibitors in a 
capacitating condition devoid of Ca2+ resulted in aberrant P-Tyr113, along with observation 
of delocalization of pCaMKII signal in Catsper null mice14,  a role of CaMKII and CaMKIV 
in sperm capacitation and fertilization is proposed, and warrants further investigation.  
Conflicting data exists for the role of CaMKIV in fertilization. Some reported 
targeted mutagenesis of the CaMKIV isoform did not affect male infertility146 while some 
reported loss of CaMKIV resulted in decreased sperm motility and infertility due to 
impaired spermiogenesis in late elongating spermatids147. Moreover, these authors 
reported that loss of camk4 gene disrupted the exchange of basic nuclear proteins on 
chromatin. One such example is the loss of protamine-2 and prolonged retention of 
transition protein-2 (Tnp2)147. To add on to the significance of these kinases on sperm 
motility and capacitation, our group used specific inhibitors of CaM kinase; KN62 and 
KN93 and evaluated their effects on sperm motility. We demonstrated that CaM kinase 




parameters such as sperm viability, P-Tyr, and acrosome reaction were not affected148. 
Moreover, work by Ignotez and Suarez demonstrated that CaMKII plays a role in 
hyperactivation of bovine sperm. Despite these findings, biochemical mechanisms on 
how CaM kinases affect sperm motility and capacitation process is not well understood. 
1.8 Hypothesis and Specific Aims: 
Radial spokes form the structural component of axoneme in flagellated cells 
including Chlamydomonas and mammalian sperm. Genetic mutations in most of the 
members of these proteins have been reported to impair flagellar motility. Even though 
cAMP/PKA dependent phosphorylation of axonemal proteins has been associated to 
hyperactivation of sperm motility and capacitation, identities of the proteins and the exact 
site that undergo capacitation associated changes in phosphorylation are not well 
understood. As a part of our work described in Chapter 2, we hypothesize that radial 
spoke proteins are phosphorylated during sperm capacitation and regulates 
events necessary for successful fertilization. This hypothesis gives rise to some basic 
questions such as: which phosphopeptides are enriched in capacitated sperm? Are those 
enriched phospho-peptides related to the family of radial spoke proteins? Does PKA 
regulates phosphorylation of those enriched phosphopeptides? Is this phosphorylation 
event important for sperm motility and hyperactivation? 
Sperm capacitation is regulated by two parallel pathways; one by the HCO3- 
dependent activation of cAMP/PKA pathway and other by the activation of Ca2+ or 
Ca2+/CaM-dependent protein phosphatases (calcineurin) and protein kinases (CaMKII 
and CaMKIV). Sperm from CatSper (a principal sperm specific Ca2+ channel) null mice, 




fertilize the egg in vivo or in vitro. Moreover, pharmacological inhibition of CaM/ Ca2+ in a 
capacitating media devoid of Ca2+ also showed aberrant increase in P-Tyr that were 
similar to the one displayed by CatSper null mice in a normal capacitating condition. 
Despite the significance of Ca2+ or Ca2+/CaM in sperm capacitation there is no clear 
understanding how these downstream targets of CaM/ Ca2+ are regulated. Thus, as a 
part of work in Chapter 3 and 4, we hypothesize that Ca2+/CaM-dependent signaling 
molecules are present in mouse sperm and participate in capacitation associated 
events. 
To study these hypotheses, we proposed following specific aims: 
1. Specific Aim 1: Identify which specific protein phosphorylation sites change their      
phosphorylation status in vivo as a result of the mammalian capacitation process 
2. Specific Aim 2: Characterize the most relevant phospho-peptide from aim 1 and 
demonstrate its significance in sperm physiology through molecular, evolutionary, and 
biochemical approaches.  
3. Specific Aim 3: Investigate if calcineurin regulates cAMP/PKA pathway and affects 
other physiological functions in mouse sperm 
4. Specific Aim 4: Characterize the presence and localization of Ca2+ signaling molecules 










SPERM CAPACITATION IS ASSOCIATED WITH PHOSPHORYLATION OF THE 




2.1 Introduction  
During epididymal maturation, mammalian sperm acquire the ability to move 
progressively 25. However, to fertilize metaphase-II eggs, sperm require an additional 
maturation step in the female reproductive tract known as capacitation. At the cell 
biological level, capacitation is characterized by changes in the sperm motility pattern 
known as hyperactivation and by the preparation for an exocytotic reaction of the 
acrosomal vesicle 26. Molecularly, capacitation is associated with a fast HCO3−-
dependent activation of the atypical adenylyl cyclase Adcy10 (aka sAC) and a consequent 
increase in cAMP levels and Prkac (aka PKA) activation. Although it is well established 
that PKA starts a phosphorylation cascade leading to capacitation, the identity of 
downstream effectors is not well understood. Capacitation-associated changes in the 
phosphorylation status of proteins have been studied by western blot analyses using anti-
phospho antibodies73,89,149. While this approach is relatively straightforward, it is not 
sufficient to identify de novo phosphorylation sites and can only be used when a particular 
phosphorylation site is already known 14.  
Post-translational modifications such as phosphorylation can also be determined 
and quantified using proteomic approaches7–9,14,150. Previously, our group used 
immobilized metal affinity chromatography (IMAC) for phosphopeptide enrichment 




7. However, this study did not reveal which of these sites undergo phosphorylation during 
capacitation. To identify sequences that show a change in their phosphorylation status, 
we used a differential isotopic labeling strategy in a subsequent manuscript to compare 
phosphopeptides derived from both capacitated and non- capacitated mouse sperm 
proteins 9. As part of that study, the relative quantification of 53 phosphorylation sites was 
reported. In the present work a similar approach was used, which led to the identification 
of an additional peptide sequence showing increased phosphorylation in capacitated 
sperm. This peptide corresponded to a PKA-consensus sequence (RRXS/T) in the N-
terminal region of the mouse radial spoke head protein 6a (Rsph6a). Although homologs 
of this protein could be found throughout evolution, including in the flagellated algae 
Chlamydomonas reinhardtii, the N-terminal domain containing the above-mentioned 
phospho site was exclusively present in eutherian mammals.  
Radial spokes are T-shaped structures formed by multiple protein subunits and 
are found in the axoneme of eukaryotic cilia and flagella 151. Radial spoke proteins play a 
role connecting the central pair of microtubules with the outer ones and are essential for 
motility and for the characteristic bending pattern of any given axoneme 151 . As part of 
this work we investigated the evolution of Rsph6a, its gene expression pattern, and its 
localization in mature mouse sperm. We confirmed that Rsph6a mRNA is expressed ex- 
clusively in testicular germ cells during meiosis and showed that this gene protein product, 
Rsph6a, remains in mature sperm associated with the cytoskeletal flagellar structures. 
Finally, 2D PAGE western analyses revealed that in capacitated sperm a portion of this 
protein displays more acidic isoelectric points (IP) and that these changes in IP were 




2.2 Results  
2.2.1 Relative quantification of phosphopeptides by differential isotopic labeling  
To increase our understanding of the extent of protein phosphorylation in mouse 
sperm incubated in conditions that either support or do not support capacitation, we used 
the approach of Fisher esterification with differential isotopic labeling as described 
previously 9. An additional phosphopeptide (R.RApSQGpSeR.A) which had not been 
observed in our previous analyses was found in this study. The relative extent of 
phosphorylation on the serine residues within this peptide was calculated based on three 
independent biological replicates of capacitated and noncapacitated sperm. In each 
replicate, samples were analyzed in two different experiments as previously described 9. 
First, capacitated sperm extracts were labeled with nondeuterated Fisher esterification 
reagent (Figure 2.1A, d0 cap) and noncapacitated sperm extracts with deuterated 
reagent (Figure 2.1B, d3 noncap). The second analysis was carried out using the reverse 
isotopic labeling scheme, in this case capacitated sperm extracts were labeled with 
deuterated reagent (Figure 2.1C, d3 cap) and noncapacitated sperm extracts with 
nondeuterated reagent (Figure 2.1D, d0 noncap). The square root of the product of the 
ratios: Cap(d0) Noncap (d3) × Cap(d3) Noncap (d0) was then calculated for each of the 
three independent replicates. This analysis indicated an average increase in 
phosphorylation of 9.53-fold ± 0.57 at these sites in capacitated mouse Rsph6a relative 
to a noncapacitated extract. As control, in each of the replicates, the change in 
phosphorylation at the tyrosine residue in the peptide K.YLpYAMR.L from hexokinase 




fold ± 0.07 which is consistent with previous findings indicating that the extent of tyrosine 
phosphorylation in hexokinase type I does not change during capacitation 5,9. 
 
The identified phosphopeptide sequence R.RApSQGpSeR.A was then used to 
search for candidate proteins in the NCBI database, using protein–protein BLAST. Two 
isoforms of the mouse Rsph6a (aka RSHL1) demonstrated 100% identity with the query 
sequence (Figure 2.2A, see the phosphopeptide sequence in red, boldface, and with 
larger font). Both isoforms corresponded to the Rsph6a gene sequence (Gene ID: 83434). 
The mouse Rsph6a gene homologs could then be traced back to the metazoan-protozoan 
divergence (Ensembl Genomes gene tree), and it was found that the Rsph6 gene had 
gone through several duplications along lineages (Figure 2.2B). The Bayesian 
phylogenetic analysis (Figure 2.3A) yielded two Rsph eutherian subtrees, which reflect 
the occurrence of a significant duplication event. The presence of two of these sequences 
in the wallaby and in the Tasmanian devil (Wasabi alignment and tree) indicates that the 
duplication occurred in the Therian (placentals and marsupials) common ancestor. In 
these two latter cases, however, the corresponding coding sequence does not start with 
an ATG, indicating a loss of function and pseudogenization in marsupials (and thus were 
excluded from the phylogenetic analysis). As a result of this event, Eutherian species 
have two paralogs: Rsph6a and Rsph4a. Both copies have a longer N-terminus compared 
to non-Therian species (ca. 200 additional residues in both proteins) (Figure 2.3B). In 
addition, it is worth noting that, despite both paralogs being highly conserved, the Rsph6a 
N-terminus has little homology with that of Rsph4a in placental mammals (Figure 2.4A 





2.2.2 Rsph6a is expressed exclusively in testicular germ cells  
 
Rsph6a is found in two splicing variants in the NCBI database. The first one, 
Rsph6a isoform I1, consists of six exons, while in the alternative form, the third 765-bp 
exon is skipped to produce a second isoform, Rsph6a I2 (Figure 2.6A). Forward and 
reverse oligonucleotides, encoding for sequences in the six exons, were used to evaluate 
Rsph6a mRNA expression by RT-PCR. Confirming previous reports 39,152, all Rsph6a 
amplicons were found exclusively in the testis (Figure 2.6B). On the other hand, the 
somatic homolog Rsph4a was expressed in brain, kidney, and in cilia containing tissues 
such as lung, trachea, and oviduct (Figure 2.6B). When testicular mRNA was obtained 
from mice of different ages, Rsph6a transcripts were found in mice that were 2 weeks old 
or older (Figure 2.6C) suggesting that Rsph6a expression starts during meiosis 153. RT-
PCR amplification using F1-R1 primers revealed at least two bands with expected 
molecular sizes (considering the primer annealing site) representing I1 and I2 transcripts. 
These results were further validated by quantitative RT-PCR analysis using one of the 
primer sets (F4/R4) (Figure 2.6D). In situ hybridization analysis indicated that Rshp6a 
mRNA expression is restricted to spermatocytes (Figure 2.6E). As positive control for the 
in situ hybridization experiments, we confirmed exclusive postmeiotic expression of testis-
specific serine kinase 6 (Tssk6) mRNA in elongating spermatids (Figure 2.6E) as 
previously described 154,155. In both cases, negative controls were conducted using the 
respective sense probes (Figure 2.7). 
 





To investigate the fate of Rsph6a after spermatogenesis, monoclonal antibodies 
were custom-made against two different N-terminal peptide sequences (mAb E3 raised 
against QRGSRSSQGSQD and mAb E2 raised against PSQTRRASQGSE) (see 
underlined sequences in Figure 2.2A). To validate these antibodies, the two Rsph6a 
splicing variants (isoforms I1 and I2) were expressed in E. coli as His-tagged recombinant 
proteins. In control experiments, both protein isoforms of an apparent molecular weight 
(MW) of 81 KDa (isoform I1) and 60 KDa (isoform I2) were recognized by the anti-His 
antibody (Figure 2.8) in western blot analyses. Both Rsph6a isoforms were also 
recognized by mAb E3 (Figure 2.9A, left panel) and by mAb E2 (Figure 2.10A, left panel) 
and, in both cases, the signal was competed out by incubation with the respective 
antigenic peptide (Figure 2.9A and Figure 2.10A, right panels). Then, to evaluate the 
presence of Rsph6 in noncapacitated and capacitated sperm samples, in vitro sperm 
capacitation experiments were performed. Proteins from noncapacitated and capacitated 
sperm samples were extracted and analyzed by western blot. The E3 antibody 
recognized three proteins of apparent MW of approximately 110, 60, and 37 KDa, 
respectively (Figure 2.9B, left panel). All these proteins were no longer detected after 
blocking the antibody with the respective antigenic peptide (Figure 2.9B, right panel). The 
approximately 110 and the 60 KDa proteins were also recognized by E2; however, this 
antibody recognized an additional protein of approximately 75 KDa and did not recognize 
the approximately 37 KDa band (Figure 2.10B, left panel). Both antibodies were made 
against different epitopes and it is possible that differences in the western blots are due 
to nonspecific cross-reaction. Similar to results with mAb E3, these bands were fully 




2.10B, right panel). In immunofluorescence assays, both antibodies stained the whole 
sperm flagellum and the signal was eliminated by pre-incubation with their respective 
antigenic peptide (Figure 2.9C and Figure 2.10C). Finally, consistent with a role in the 
axoneme, Rsph6a was found to be insoluble in 1% Triton X-100. Moreover, a significant 
fraction of Rsph6a, including the 60-KDa band, remained insoluble even after the sperm 
were boiled in Laemmli sample buffer without the addition of reducing agents (Figure 
2.11).  
 
2.2.4 Rsph6a phosphorylation during sperm capacitation is dependent on PKA 
 
Our MS/MS analysis indicated that the N-terminal domain of Rsph6a undergoes 
increased phosphorylation during capacitation. Therefore, we performed phosphorylation 
site predictions using three online tools: the NetPhos 3.1 Server, the pkaPS, and the GPS 
Web Server. Table 1 shows all phosphosites predicted by Netphos 3.1, and PKA-specific 
phosphorylation sites predicted by pkaPS and GPS, both for mouse and human Rsph6a. 
Five of these sites were predicted by all three methods and showed the highest 
phosphorylation scores in all of them. Although there were more candidate sites predicted 
by one or two methods, the aforementioned phosphosites are predicted to be PKA 
phosphorylation sites. The first site on the N-terminus is a serine located in the 17th 
residue of the mouse Rsph6a and coincides with the serine at site 21 in the human 
protein. This site matches the phosphorylation site found using mass spectrometry 
(Figure 2.2A, see sequence in boldface, red, and larger font) and is conserved in the 
unique eutherian mammalian species Rsph6a N-terminus sequence. Together, these 




modification. The second site found corresponds to the serine at the 29th position of the 
human RSPH6A, and although it is a conserved serine, it is predicted to be 
phosphorylated by PKA in human but not in mouse. The third site found using 
bioinformatics in mouse corresponds to the serine at the 52nd residue of Rsph6a. This 
site is not ubiquitous among mammals, but instead is restricted to rodents. Similarly, 
although the serine at the 62nd position of the human RSPH6A is conserved among most 
placental mammals, it is predicted to form part of a PKA cognate in human but not in 
mouse. The last site is common to both human and mouse (residues 519 and 510, 
respectively), and it corresponds to a serine conserved among 36 out of 38 Rsph6a 
protein sequences analyzed. Because phosphorylated proteins have more acidic IPs 156, 
we used 2D gels to analyze Rsph6a behavior in mouse sperm incubated in media that 
either supported or did not support capacitation. The low solubility of proteins under 
nonreducing conditions was used to eliminate a significant amount of protein background, 
as described in the Methods section. The remaining (cell pellet) fraction was extracted 
with 2D urea buffer containing DTT. In these conditions four spots were detected in 
noncapacitated sperm lysates (Figure 2.12A), in the MW range corresponding to the 
approximately 110 KDa and the approximately 60–75 KDa Rsph6a isoforms. When the 
same experiments were conducted using sperm incubated in conditions that support 
capacitation (addition of BSA 5 mg/ml and HCO3− 15 mM), the approximately 110 and the 
75 KDa spots showed a partial protein shift to a lower, more acidic IP (Figure 2.12B). 
The lower IP is consistent with phosphorylation of these protein isoforms in capacitated 
sperm. Considering phosphosite predictions, 2D analyses were also conducted in sperm 




described inhibitor of the atypical adenylyl cyclase Adcy10 (aka sAC) 157 (Figure 2.12C 
and D, respectively). Both inhibitors blocked the observed changes in Rsph6a IP. 
 
2.3 Conclusion 
Capacitation is a lengthy process associated with biochemical changes occurring 
in different sperm compartments. At the molecular level, cAMP-dependent 
phosphorylation triggers an increase in flagellar beating and initiates additional 
phosphorylation cascades leading to hyperactivation and preparation for the acrosome 
reaction 20,158. However, the identity and role of phosphorylated proteins has not been 
fully established. Toward this goal, we previously described a differential isotopic labeling 
strategy coupled with IMAC-based phosphopeptide enrichment and tandem mass 
spectrometry9. This approach allowed us to estimate the relative extent of 
phosphorylation on 42 different phosphopeptides from capacitated mouse sperm. As a 
part of our work in Chapter 2, an additional phosphopeptide was identified using the same 
methodology. This phosphopeptide (R.RApSQGpSeR.A) corresponded to the radial 
spoke head protein Rsph6a. An elaborate discussion on the structure of sperm axoneme 
and radial spoke proteins is described above (chapter 1, section 1.3) and on Figure 
2.13.  
Although radial spoke morphology has many similarities across species, the 
proteins that form this structure have diverged during evolution 151. In the case of Rsph6a, 
phylogenetic analysis revealed that this protein originated by duplication in a Therian 
common ancestor. This event gave rise to two paralogs, Rsph6a and Rsph4a, which 




tree and alignment). The outcome of this process was the acquisition of a novel first exon 
leading to the enlargement of the N-terminus of both proteins, approximately 200 residues 
longer than non-Therian species. This novel N-terminus shows poor levels of identity 
between both paralogs (Figure 2.4, 2.5). After duplication, a new gene copy might acquire 
either a new function (neofunctionalization), a complementary partitioning of the original 
function between two duplicates (subfunctionalization), or pseudogenization 
(nonfunctionalization) by mutational decay 159,160. Rsph4a retained the canonical function, 
reflected by the fact that it is ubiquitously expressed in multiple tissues, and also because 
it is the homolog retained by marsupials. In contrast, Rsph6a is only present in placental 
mammals, its expression is restricted to the testes, and it has a novel Eutherian-specific 
function. The Rsph6a N-terminus may have modified the protein's original function, but 
its differential expression may have evolved due to modifications in transcriptional 
regulation. In marsupials, which have a homologous sequence but in which the ORF was 
lost, Rsph6a underwent mutations resulting in a nonfunctional pseudogene. Being a radial 
spoke protein, Rsph6a would be expected to be incorporated into the axoneme in 
spermatids during spermiogenesis. However, our RT-PCR and in situ hybridization data 
indicate that Rsph6a mRNA is expressed in spermatocytes. A similar expression pattern 
has also been observed for murine Tmem146, a gene that encodes for CATSPERδ, a 
protein subunit proposed to be required for proper assembly and/or transport of the 
CATSPER ion channel complex in mature sperm. One of the alternative splice variants 
of mouse CATSPERδ, encoded by Tmem146-s mRNA, only appeared at postnatal day 
17 of testis development and its expression was restricted to spermatocytes 13. More 




how it is incorporated into the sperm flagellum. 
The interaction between radial spoke proteins and the central microtubule pair is 
essential for modulation of ciliary and flagellar motility by cyclic nucleotides, 
phosphorylation, calcium, and calmodulin 151. Coincidently, mouse sperm capacitation is 
regulated by molecular pathways that involve cAMP 56, phosphorylation events 5,113,158, 
and calcium 113. We found Rsph6a to be phosphorylated more extensively in the N-
terminal sequence R.RApSQGpSeR.A during capacitation. This sequence presents the 
consensus PKA substrate motif RRXS/TY 161 suggesting that Rsph6A is a PKA substrate. 
This hypothesis was supported by two-dimensional electrophoresis results indicating that 
the shift in Rsph6a IP observed in capacitated sperm was prevented by incubation with 
the PKA inhibitor H-89 and with LRE1, a recently described Adcy10 inhibitor 157. In 
addition, bioinformatics analyses predict this Rsph6a N-terminal site to be a PKA 
consensus sequence. This analysis also predicts three additional phosphorylation sites 
for this protein, all of them containing consensus sequences for PKA phosphorylation. 
Altogether, these results suggest that Rsph6a is phosphorylated by PKA during sperm 
capacitation. 
Another second messenger intrinsically connected to the regulation of flagellar and 
ciliary movement is Ca2+. Studies in Tetrahymena have shown that the Rsph6a and 
Rsph4a paralogs, p62 and p66, bind to Ca2+/Calmodulin columns 162. Sequence 
comparisons indicate that at least one of the Ca2+/calmodulin-predicted binding sites 
for Tetrahymena has been conserved in the same position in both Rsph4a and Rsph6a 
(Figure 2.4A, gray-boxed sequence). Intracellular Ca2+ concentrations modulate 




including Paramecium 163, Chlamydomonas 164,165, and sea urchin sperm 166. In 
mammalian sperm, Ca2+ is involved in the regulation of hyperactivated movement 167. 
Altogether, there is compelling evidence that Ca2+ ions play essential roles in the 
regulation of flagellar motility; however, the high number of Ca2+-binding proteins in 
eukaryotic flagella and cilia makes it difficult to assign particular roles to any given protein. 
Therefore, the most probable scenario is that multiple Ca2+ sensors, among them radial 
spoke proteins, are required for motility control 151. 
Functional characterization of each of the radial spoke proteins will require loss-
of-function studies such as the generation of knockout models or analysis of naturally 
occurring genetic mutations. In this regard, human ciliopathies have provided important 
insight into the role of axonemal proteins. In particular, Rsph1 152, Rsph9, and Rsph4a 168 
have been linked to primary ciliary dyskinesia, a disease characterized by defects in 
motile cilia. Although no other radial spoke proteins have been knocked out yet, specific 
axonemal defects have been mapped by eliminating other axonemal proteins (for review, 
see 36). Many of these transgenic models have unique phenotypes in motile cilia and have 
been instrumental in elucidating radial spoke and central pair functions. However, in most 
of these knockout models, elimination of a particular protein affects the overall 
organization of the axoneme, making it difficult to determine the specific role of any given 
protein. In addition, these approaches are generally silent regarding signaling events 
involved in motility regulation. The use of newly discovered gene editing technologies 
such as Crispr/Cas9 169 will allow the generation of point mutation, knock-in transgenic 
models that target specific amino acids in axonemal proteins. Identification of those sites 




determine which residues are key targets for further experimentation and mutation to 
elucidate the signaling pathways controlling capacitation and normal sperm function. 
(Note: This part of my work from Chapter 2 has been published in the Journal 

























CALCINEURIN REGULATES PKA MEDIATED FEEDBACK CONTROL OF cAMP 




Mammalian sperm cannot fertilize eggs immediately after ejaculation. To gain 
fertilizing ability, sperm need to reside in the female reproductive tract for a finite period 
of time 271,2. During this time, sperm undergoes several physiological changes that include 
hyperactivation of sperm motility, increase in protein tyrosine phosphorylation and 
preparation of sperm for acrosome reaction. Collectively, these changes are called 
capacitation 5,6. In the female tract, as soon as sperm come in contact with HCO3- and 
Ca2+, they start a vigorous flagellar movement known as activated sperm motility. At the 
molecular level, this activated sperm motility is correlated with increase in PKA activity 
mediated by synergistic stimulation of an unique type of soluble adenyl cyclase known as 
Adcy10 (aka sAC) by HCO3- and Ca2+3. Upon stimulation, sAC metabolizes ATP and 
promotes synthesis of cAMP molecules, which then activates protein kinase A (PKA). 
Activation of cAMP/PKA pathway then leads to the phosphorylation of various PKA target 
proteins in their Ser/Thr residues and initiates activation of several signaling pathways 3. 
However, this initial activation is not sufficient for sperm to achieve capacitation. For 
sperm to achieve capacitation, they need to reside in the female tract for extended period 
of time1,2. Capacitation can also be achieved in vitro by incubating sperm for at least 45 
min in a media containing Ca2+, HCO3- and bovine serum albumin (BSA)3,27 .At this time, 




molecular level, such changes in motility pattern are correlated with an increase in 
tyrosine phosphorylation of sperm flagellar proteins 4–6.  
 cAMP controls several signaling events during sperm capacitation and its levels 
during this process are quiet dynamic. Depending on the need to fine tune PKA signaling, 
cAMP levels are regulated by constant synthesis and degradation events. In mouse 
sperm, cAMP levels peak within 30 s of exposure to HCO3- and Ca2+ and returns to basal 
level in minutes 58,72. Consistently, PKA activity also reaches its maximum activity in less 
than a minute upon exposure to these conditions. However, the PKA substrates remain 
phosphorylated71–73. Such dynamics in cAMP levels can be explained by crosstalk 
between cAMP and Ca2+ signaling pathways. On one hand, Ca2+ positively promotes 
cAMP synthesis by direct stimulation of sAC; on the other hand, Ca2+ binds with 
calmodulin (CaM), which activates phosphodiesterase (PDE) and promotes cAMP 
degradation 19,64,171,172. Beside PDE, PKA has been shown to control cAMP synthesis in 
a negative feedback loop. The work by McKnight and colleagues showed elevated cAMP 
levels in the sperm of the mice treated with H-89, a pharmacological inhibitor of PKA 
incubated under capacitating conditions. The increase in cAMP levels were also observed 
when measured in sperm from the mice lacking the sperm specific PKA catalytic subunit 
(Cα2). Their data indicated that PKA controls cAMP synthesis through PKA-mediated 
inactivation of sAC by phosphorylation 20. Nonetheless, there is no clear understanding 
how this feedback loop is regulated, and how it fine-tunes PKA signaling during 
capacitation. 
 In the present work, we hypothesize that Ser/Thr phosphatases are involved in the 




based on the aforementioned previous finding from McKnight and group that sAC is 
inhibited in a PKA feedback loop during capacitation 20. Unlike protein kinases, little is 
known on the role of protein phosphatases (PPs) in capacitation.  
As previously mentioned in Chapter 1, mammalian phospho protein phosphatases 
(PPP) are divided into 7 subtypes, PPP1-PPP7, with a total of 14 catalytic subunits. For 
the most recent classification of Ser/Thr phosphatases including their isoforms and 
alternative names, see the review. Western blot analysis has shown the presence of 6 
catalytic subunits in human sperm: PPP1CB (PP1), PPP1CC2 (PP2), PPP2CA (PP2A), 
PPP4C (aka PPX), and PPP6C (PP6)173. Of these catalytic subunits PP2 and has been 
reported to present also in mouse, hamster, and bull spermatozoa 99. Similarly, the 
presence of PPP3CC (PP2B)  has been reported in mouse113,127 and bovine 
spermatozoa19,128. Given the high sequence homology among PPP subfamilies, it is 
extremely difficult to understand the precise role of each PPP members in sperm 
physiology. Interestingly, it has been reported that each member of PPP family presents 
a sensitivity profile towards various toxin inhibitors. Depending on the inhibition or 
enhancement on the activity of the PPP at effective concentration, which type of PPP is 
inhibited can be predicted 174. Okadaic Acid (OA) at nano-molar concentration (IC50 
=0.5nM) are effective at inhibiting the activities of PP2A, PP4, and PP6 than it is for PP1 
and PP5 which would require higher concentration (IC50 =10-50nM or higher)175,176. The 
typical example of the effective concentration inhibition of PPP family was reported in the 
work of Vijayaraghavan where the authors observed maximum activation of caput sperm 
at 5M okadaic concentration suggesting the involvement of PPP1 in this process 35. In 




PP2C175,176. In the same manner, Calyculin A is a potent inhibitor of PP1 (IC50 =0.3-0.7nM) 
than PP2A (IC50 = 0.5-1.0nM) and is completely resistant to the inhibition of PP2B177.  
 
 The first report that demonstrated the link between Ser/Thr phosphatases and 
sperm capacitation came from the group of Furuya and colleagues. In this work, authors 
evaluated the effect of Ser/Thr phosphatases inhibitors; Okadaic Acid (OA), and Calyculin 
A (CL-A) on capacitation process using chlortetracycline (CTC) fluorescent assay. Their 
results showed OA and CL-A induced rapid appearance of B pattern, which is associated 
with the capacitation status of the sperm103. Similarly, group of Goto and Harayma also 
investigated the effect of calyculin A (PP1/PP2A inhibitor) on sperm capacitation. Instead 
of looking at B pattern, this group used antibody directed against phosphorylated PKA 
substrates that recognize either RXXpS/pT or RRXpS/pT consensus site to monitor PKA 
activity. Finding of their result not only showed increased PKA phosphorylation when 
sperm were incubated with calyculin A in capacitating condition, but also increased 
percentages of hyperactivated sperm104. Similarly, previous work from our lab 
demonstrated that inhibition of Src family kinase inhibitors block PKA substrate 
phosphorylation, sperm motility and in vitro fertilization. Interestingly, these effects were 
overcome when sperm were incubated with OA and CL-A at concentration reported to 
affect only PP2A73. This manuscript concluded that cSrc family kinases were responsible 
to block PP2A during capacitation and that the inhibition observed with cSrc kinases 
inhibitors was due to enhance activation of PP2A73.  
 While there are still few studies on PP1 and PP2A, there are fewer studies to show 
involvement of calcineurin in sperm capacitation. In addition, recently it was shown that 




associated with reduced midpiece flexibility during epididymal maturation127. On the other 
hand, in immune cells, calcineurin has been shown to activate T cells by 
dephosphorylating the transcription factor NFAT in which dephosphorylated NFAT 
translocates to the nucleus and induces the expression of interlukin-2 (IL2). However, this 
process can be suppressed by two potent calcineurin inhibitors; Cyclosporin A (CsA) and 
FK506, in the presence of their respective cytoplasmic immunophilin protein cyclophilin 
A and FKBP12114,116.  
 As a part of our work in this chapter, we validated the hypothesis proposed by 
McKnight group and present evidence that calcineurin regulates PKA-mediated negative 
feedback of cAMP synthesis by counteracting the inhibitory phosphorylation of sAC or of 
some intermediary enzyme. 
 
3.2 Results 
3.2.1 Negative Feedback Control of cAMP Synthesis During Sperm Capacitation  
Feedback control of cAMP synthesis in many somatic cells can be achieved either by 
activation of PDE or inhibition of adenylyl cyclase activity by PKA 178. In sperm, Nolan, M. 
A. et al first reported the involvement of PKA in feedback control of cAMP synthesis. In 
this study, using ELISA based assay, the authors measured cAMP levels in the sperm 
collected from wildtype and from mice lacking the testis-specific PKA catalytic subunit of 
(Cα2).These experiments were conducted in in media that support capacitation 
supplemented with IBMX to block cAMP degradation by PDEs. Their results showed 
elevated levels of cAMP in sperm from Cα2 null mice compared to wildtype. Moreover, 




findings with the genetic model. Consistent with findings using Ca2 null mice, H-89 also 
elicited cAMP rise in the WT sperm when incubated in capacitating conditions 
supplemented with IBMX20. Together, their data suggested that PKA is involved in 
feedback control of cAMP synthesis, and it is mediated through direct or indirect 
inactivation of sAC and not through IBMX-sensitive PDE. A typical model of feedback 
control of cAMP synthesis during sperm capacitation is shown (Figure 3.1A).  
 Despite these data, in the absence of PKA inhibitors, cAMP synthesis is not 
blocked. We hypothesize that to maintain a threshold level of cAMP, the phosphorylation-
dependent negative feedback was counteracted by Ser/Thr phosphates involved in direct 
or indirect activation of sAC by dephosphorylation.  To test this hypothesis, we started by 
confirming that PKA inhibitors increased cAMP levels in sperm incubated in conditions 
that support capacitation. To measure cAMP levels we used a 32P-labeled ATP 
radioactive kinase assay previously validated 73. For this purpose, sperm were incubated 
in capacitating condition for 60 min with or without H-89 in the presence or absence of 
IBMX and sperm lysates were prepared for cAMP extraction. cAMP extracted from each 
condition was then measured as previously described 56 using a cAMP standard curve 
run in parallel with known concentrations of cAMP  Sperm intracellular cAMP levels were 
then determined by interpolating specific PKA activity values from the cAMP standard 
curve for each assay condition. An example of cAMP calibration curve prepared from 
three independent experiments is shown (Figure 3.1B). Consistent with previous study, 
cAMP levels were significantly increased (~9 folds higher than Cap controls) when sperm 
were incubated in capacitating conditions in the presence of H-89 and IBMX. This confirm 




negative feedback of cAMP synthesis20. However, increased cAMP levels by H-89 were 
seen only in the presence of IBMX. If the negative feedback of cAMP levels were caused 
by up-regulation of PDE by PKA, increased cAMP levels should have also been seen in 
the absence of IBMX. Thus, these results suggest that PKA negatively controls cAMP 
synthesis, by direct or indirect inactivation of sAC, but not by activation of PDE (Figure 
3.1C).  
 In the previous study, authors used H-89 to inhibit PKA activity, but its inhibitory 
activity is non-selective and has been known to inhibit other kinases179. To further verify 
these results, we used Rp-cAMPS, a specific cell permeable analog of cAMP180, which 
competitively binds to the regulatory subunit of PKA and blocks cAMP-induced PKA 
activation. To further test the PKA-dependent negative feedback on cAMP synthesis, we 
incubated sperm with or without Rp-cAMPS in a capacitating condition and analyzed 
phosphorylation status of PKA substrates. As expected, incubation of sperm with Rp-
cAMPS inhibited PKA substrate phosphorylation (Figure 3.2A). These results were 
consistent when we analyzed PKA activity in vitro kinase assay. Incubation of sperm 
lysates with Rp-cAMPS in the presence of cAMP significantly inhibited PKA activity 
(Figure 3.2B). After validating Rp-cAMPS inhibits PKA activity in live cells as well as in 
sperm lysate, we measured cAMP levels in the sperm incubated with Rp-cAMPS in a 
capacitating condition supplemented with IBMX as described in the H-89 experiment 
above. Incubation of Rp-cAMPS in these conditions elicited similar ~9-fold increase in 
cAMP levels than the control capacitated sperm incubated without Rp-cAMPS (Figure 
3.1D). Together, all these data from our work and previous work strongly suggest PKA is 




or indirect inactivation of sAC. 
3.2.2 Involvement of Serine/Threonine Phosphatases in cAMP/PKA Pathway 
At the molecular level, sperm capacitation is associated with the activation of 
cAMP/PKA pathway. Activation of this pathway results in the phosphorylation of Ser/Thr 
residues of PKA target proteins, which then initiates activation of several signaling 
cascades. Even though, it is understood that Ser/Thr phosphorylation state reflects the 
balance between enzymatic activities of kinases and protein phosphatases, little is known 
about the involvement of protein phosphatases in capacitation. Our main hypothesis is 
that Ser/Thr phosphates counteract the PKA-dependent negative feedback on cAMP 
synthesis and are involved in direct or indirect activation of sAC. To test this hypothesis 
and investigate which Ser/Thr phosphateses are involved in capacitation, we first used a 
battery of well-validated Ser/Thr phosphatase inhibitors. Inhibition of protein phosphatase 
PP1 and PP2A with Okadaic Acid (OA) up-to 1μM did not affect PKA substrate 
phosphorylation during 60 min of sperm capacitation. Moreover, Calyculin A (CalyA), a 
potent inhibitor of both PP1 and PP2A, enhanced PKA substrate phosphorylation at 
100nM concentration consistent with the findings by Goto & Harayama104 (Figure 3.3A). 
On the other hand, inhibition of calcineurin using two completely different 
immunosuppressant drugs known to block calcineuring in other systems, cyclosporin A 
(CsA) and FK506, drastically reduced PKA substrate phosphorylation suggesting a 
unique role of calcineurin in the regulation of cAMP/PKA pathway (Figure 3.3B, C)  
3.2.3 Analysis on the Presence of Calcineurin Isoforms, Cyclophilin A and FKBP12 
in Mouse Sperm 




pathway. To confirm the presence of calcineurin in mouse sperm, western blot analysis 
was performed using calcineurin specific antibodies. In mammals, three isoforms of 
catalytic subunits (PPP3CA, PPP3CB, and PPP3CC) and two isoforms of regulatory 
subunits (PPP3R1 and PPP3R2) have been reported. Of the three catalytic subunits and 
two regulatory subunits only PPP3CC (~57KDa) and PP3R2 (~25KDa) are strongly 
expressed in mouse testis and sperm protein lysates (Figure 3.4Ac, d). In contrast, other 
catalytic isoforms (PP3CA and PPP3CB) were highly expressed in mouse brain lysates 
but no expression of these isoforms were found in testis and sperm protein lysates 
(Figure 3.4Aa, b). These results are consistent with the findings by Miyata et al. To 
investigate the localization of calcineurin in sperm, immunofluorescence was performed 
using antibody targeting sperm specific PPP3CC isoform. Immunofluorence analysis 
confirmed that PPP3CC was strictly localized to the principle piece of sperm flagellum in 
agreement with the previous findings14 (Figure 3.4B).  
 Calcineurin is the target of the two immunosuppressant drugs Cyclosporine A 
(CsA) and FK506. Their mode of action has been shown in immune cells. CsA and FK506 
binds to immunophillins; Cyclophilin A and FKBP12 respectively, and immunophilin-drug 
complex binds to the calcineurin and blocks T cell activation 114,116. To investigate the 
presence of CsA and FK506-binding proteins in mouse sperm, western blot analysis was 
performed on protein lysates from various tissues using antibodies against Cyclophilin A 
and FKBP12. Western blot analysis confirmed the presence of expected ~18 KDa 
(Cyclophilin A) and ~12KDa (FKBP12) protein bands in mouse brain, testis and sperm 
protein lysates (Figure 3.4Ca, b). These results confirmed that calcineurin is present in 




also confirmed that mouse sperm harbors two important immunophillin proteins required 
by CsA and FK506 to block calcineurin activity.  
3.2.4 Evaluation on the Effect of Cyclosporin A and FK506 on PKA Activity 
Off-target effect of pharmacological drug in an unintended protein target has made 
difficult to study many biological processes. Therefore, to control for off-target effect of 
CsA and FKBP12 on PKA, we employed in vivo and in vitro approaches to test their 
specificity. In our in vivo approach, we used dibutyryl cyclic AMP (db-cAMP), a membrane 
permeable cAMP analogue to bypass HCO3- dependent activation of sAC and directly 
activate PKA. To investigate if db-cAMP can restore PKA substrate phosphorylation after 
inhibition by CsA, sperm were incubated with or without CsA or with CsA in the presence 
of db-cAMP in a media that supports capacitation for 60 min. After capacitation, sperm 
proteins were extracted and subjected to SDS PAGE for western blot analysis. 
Immunodetection by pPKAS antibody showed inhibition of PKA phosphorylation when 
sperm were incubated with CsA. However, inhibition by CsA was completely recovered 
when sperm were incubated with CsA in the presence of db-cAMP. As expected, in 
control experiments, when sperm were incubated with H-89 in the presence of db-cAMP, 
phosphorylation of PKA substrates did not recover (Figure 3.5A). Similar results were 
observed when experiments were repeated with FK506 (Figure 3.5B). These results 
indicate that neither CsA nor FK506 affects PKA activity in vivo and support the 
hypothesis that calcineurin is the phosphatase counteracting the PKA-dependent 
negative feedback loop on cAMP synthesis. To further validate these data, PKA activity 
on sperm protein lysate was evaluated using the PKA-specific substrate, kemptide, in a 




cAMP in the presence or absence of CsA, this calcineurin inhibitor did not block PKA 
activity while H-89 did block PKA activity in the presence of db-cAMP (Figure 3.5C). 
When similar experiments were repeated with FK506, FK506 also did not inhibit PKA 
activity (Figure 3.5D). Thus, these results confirmed that both CsA and FK506 do not 
affect PKA activity in vivo and in vitro and suggest the hypothesis that calcineurin is 
involved the regulation of cAMP/PKA pathway.  
3.2.5 Evaluation of Off-target Effect of Cyclosporin A and FK506 on sAC Activity.  
 
HCO3- was shown to directly activate sAC and increase cAMP levels in many 
species that includes higher mammals as well as lower prokaryotes such as 
cyanobacteria16. HCO3- exposure induces conformational changes in sAC’s active site 
and allows proper interaction with its physiological substrate, Mg2+-ATP. In addition to 
HCO3-, sAC also function as a physiological sensor of pH, CO2, ATP and Ca2+51–53. In the 
presence of Ca2+, sAC binding affinity towards ATP increases, and the enzyme Km for 
ATP decreases making sAC more responsive to the changes in HCO3-51. In mammalian 
sperm, cAMP levels peak immediately within a minute of exposure to Ca2+/HCO3- 
suggesting an immediate action of these ions on sAC activity58,72. Consistently, when 
monitored the kinetics of PKA activity using phospho PKA substrate antibody, its activity 
also reached maximum within a minute of Ca2+/HCO3 exposure71–73. Therefore, to 
investigate the effect of CsA or FK506 on sAC, we performed time-course dependent 
capacitation of sperm. Incubation of CsA or FK506 did not immediately affect PKA 
substrate phosphorylation. Rather the inhibition of PKA substrates occurred in a time-
dependent manner and the effect started to appear between 15-30 min of capacitation 




Importantly, the calcineurin inhibitors were pre-incubated with the sperm for 15 min before 
starting capacitation by addition of HCO3- and BSA. If the calcineurin inhibitors would be 
blocking sAC unspecifically, we would expect inhibition of PKA-dependent 
phosphorylation at earlier time points. Therefore, this result suggests that the calcineurin 
inhibitors do not block sAC unspecifically. Consistently with this result, in vitro cyclase 
assays conclusively demonstrated that sAC activity is not directly inhibited in the 
presence of 10μM CsA (Figure 3.6C). Note: the adenyl cyclase activity experiments were 
conducted by our collaborators at Weill Cornell as written in the figure legend and in the 
acknowledgment section. 
 
3.2.6 Role of Voltage Gated Ca2+ Channel (Cav) in PKA Phosphorylation 
Presence of L-type (high voltage activated) and T-type (low voltage activated) Ca2+ 
channels are reported in mammalian sperm. Both immunohistochemistry and western 
blot analysis suggest the presence of all members of T-type (Cav3.1- Cav3.3) and only 
one member of L-type (Cav1.1) Cav channels in mature sperm. However, no Cav current 
was detected for any of these channels by whole patch clamp and their role in sperm 
physiology remained unknown181. To confirm if CsA or FK506 would have targeted these 
ion channels unspecifically resulting in off-target inhibition of PKA substrates, we 
investigated the role of these ion channels in PKA substrate phosphorylation. Incubation 
of sperm with L-type (verapamil) or T-type Cav inhibitors (NNC 55-0396 or mibefradil) in 
a media that support capacitation did not affect PKA substrate phosphorylation (Figure 




on the previous study that used these inhibitors to block progesterone induced Ca2+ 
response in human sperm 59. 
 
3.2.7 Involvement of Calcineurin in PKA-mediated Feedback Control of cAMP 
Synthesis 
 we hypothesized that calcineurin being a Ser/Thr phosphatase dephosphorylates sAC or 
its intermediary proteins and makes it active to promote cAMP synthesis.  If this 
hypothesis is correct, we expect that in addition to blocking PKA substrate 
phosphorylation (see Figure 3.3B, C), intracellular cAMP levels in sperm incubated with 
CsA or FK506 in a capacitating condition would be decreased. This prediction was 
confirmed; our results show that inhibition of calcineurin by CsA or FK506 significantly 
reduced cAMP levels (Figure 3.8). These results suggest that calcineurin counteract the 
PKA-mediated negative feedback loop. 
3.2.8 Role of Calcineurin in Sperm Physiology  
To investigate if calcineurin has any role in sperm physiology, we evaluated the 
effect of CsA on sperm motility and in vitro fertilization (IVF). Incubation of sperm with 
10μM CsA in a capacitating condition did not affect overall motility of sperm, but 
significantly inhibited sperm hyperactivation (Figure 3.9, top panels), a parameter 
directly related to sperm fertilization potential. Consistent with its effect in sperm 
hyperactivation, CsA significantly inhibited the fertilizing ability of sperm in IVF when 
preincubated with CsA in capacitating condition. To evaluate, if decrease in fertilization 
rate is due to the direct effect of CsA on eggs, we preincubated eggs with CsA in a similar 
manner and inseminated those eggs with control sperm. Preincubation of eggs with CsA 




conditions above, sperm and eggs were preincubated with CsA, but in the fertilization 
drop CsA was either diluted (in the case of sperm) or completely washed off (in the case 
of egg). To investigate the effect of the presence of CsA in all steps of IVF we 
preincubated both sperm and egg with CsA and also added CsA in the fertilization drop. 
Presence of CsA during sperm preincubation and in the fertilization drop further inhibited 
the fertilizing ability of sperm (Figure 3.9, lower panels). 
3.3 Conclusion 
3.3.1 General discussion  
Calcineurin (PP2B) is a Ca2+/CaM dependent Ser/Thr phosphatase involved in 
regulation of several biological processes including neurodevelopment and memory, 
immune response and signal transduction. In immune cells, calcineurin has been shown 
to activate T cells by dephosphorylating the transcription factor NFAT in which 
dephosphorylated NFAT translocates to the nucleus and induces the expression of 
interlukin-2 (IL2).this process can be blocked by two calcineurin inhibitors; Cyclosporin A 
(CsA) and FK506 114,116.  
In mouse sperm, calcineurin have been shown to confer midpiece flexibility during 
epididymal maturation. Mice lacking testis-specific isoform of calcineurin displayed 
abnormal midpiece that is bent in a direction opposite from the hook of acrosome. Owing 
to this defect in midpiece, these mice were reported infertile in both in vivo and in vitro 
conditions 127. Furthermore, in vitro treatment of sperm with calcineurin inhibitors have 
been reported to impair sperm motility and acrosome reaction128. While there are still few 
studies on other protein phosphatases (PP1 and PP2A) relating their role in sperm 




 In the present work, we tested the hypothesis that Ser/Thr phosphatases are 
involved in the regulation of cAMP levels through direct or indirect activation of sAC. This 
hypothesis is based on previous finding that PKA regulates cAMP synthesis through PKA-
mediated inactivation of cAMP synthesis in a negative feedback loop. Thus, prior testing 
our hypothesis, we validated the hypothesis proposed by McKnight group, but with a 
different approach. Using a very sensitive radioactive kinase assay and another more 
specific inhibitor of PKA, Rp-cAMPS, we showed elevated levels of cAMP in sperm under 
capacitating conditions, and hence confirmed PKA indeed is involved in feedback control 
of cAMP synthesis. To investigate if any Ser/Thr phosphatases are involved in the 
regulation of cAMP/PKA pathway, we incubated sperm with various phosphatase 
inhibitors in a capacitating condition and analyzed phosphorylation status of PKA 
substrates. Unlike PP1/PP2A, inhibition of calcineurin by CsA or FK506 blocked PKA 
substrate phosphorylation.  To investigate if inhibition of PKA substrate phosphorylation 
is due to off-target effects of CsA or FK506 on PKA or sAC, we directly measured PKA 
and sAC activity in vitro and confirmed that this is not the case. Furthermore, to investigate 
the mechanisms associated to the decrease in PKA substrate phosphorylation, we 
measured cAMP levels in the sperm treated with CsA or FK506 and found significantly 
reduced cAMP levels in these conditions. Moreover, unlike PP1/PP2A inhibitors, which 
were reported to improve sperm hyperactivation and in vitro fertilization (IVF), calcineurin 
inhibitors inhibited both events that are essential for successful fertilization. A typical 
model of regulation of cAMP/PKA pathway by calcineurin is shown in Figure 3.10. 
 




Our data indicate a unique roe of calcineurin in sperm capacitation. We found that 
biochemical inhibition of calcineurin by CsA or FK506, inhibits sperm hyperactivation and 
its ability to fertilize egg in vitro. More importantly, we demonstrated that these 
physiological impairments are not due to unspecific effect of CsA and FK506. Rather, we 
showed a mechanistic way that calcineurin is important for optimal PKA signaling in 
capacitation process. 
Moreover, previous results reported that mice lacking testis-specific isoforms of 
calcineurin are infertile127. When investigated the cause behind this infertility, the authors 
found that sperm from these mice have problem in the midpiece region, i.e, their midpiece 
are inflexible. To investigate, during which steps of sperm maturation events this problem 
occurred, the authors treated the wild type (WT) mice with CsA and FK506 for two weeks 
and investigated the effect of these drug over various days within two weeks. Their finding 
showed sperm with rigid midpiece appeared as early as 4 to 5 days of CsA or FK506 
treatment. Because it takes ~10 days for sperm to fully mature in epididymis, apparent 
effect of these drugs observed after few days of treatment suggested a role of calcineurin 
in epididymal sperm maturation. Intrestingly, during the period of CsA or FK506 treatment, 
the WT mice were infertile, and the sperm from these mice also failed to fertilize the egg 
in vitro. However, when stopped the CsA or FK506 treatment, the WT mice became fertile 
again in vivo as well as in vitro which suggested a possibility that calcineurin can be 
developed into a novel reversible contraceptive target127. Moreover, what makes 
calcineurin an attractive contraceptive target is that human sperm also harbors sperm 
specific calcineurin complex (PPP3CC-PPP3R2) which in vitro exhibited Ca2+-dependent 




from other lab suggest the possibility that calcineurin can be utilized as a novel target of 
contraception design in the future. Development of pharmacological inhibitors that can 
specifically target sperm specific calcineurin (PPP3CC and not the other isoforms) would 





























CHARACTERIZATION OF Ca2+ SIGNALING MOLECULES IN MOUSE SPERM AND 
THEIR ROLE IN CAPACITATION ASSOCIATED EVENTS 
 
4.1 Introduction 
Beside HCO3-, the role of Ca2+ in the capacitation pathway is indispensable.  Ca2+ 
regulates the cAMP/PKA pathway through direct stimulation of sAC (9). Ca2+ also binds 
with another binding partner calmodulin (CaM) and regulates activity of multiple enzymes 
such as phosphodiesterase (PDE), protein phosphatase 2B (PP2B; also known as 
calcineurin), and protein kinases; Ca2+/CaM-dependent kinase II (CaMKII) and 
Ca2+/CaM-dependent kinase IV (CaMKIV)10. The role of Ca2+ and Ca2+/CaM in sperm 
capacitation was demonstrated by genetic and pharmacological approaches. Mice 
lacking CatSper, a sperm specific Ca2+ channel, failed to achieve hyperactive motility and 
displayed aberrant/premature P-Tyr of sperm axonemal proteins, and therefore were 
infertile11–13. Consistently, inhibition of CaM inhibitors also inhibited the onset of sperm 
hyperactivation15. Nonetheless, the role of downstream targets of Ca2+/CaM in the 
capacitation process is not well understood. As a part of our work in chapter 4, we 
characterized the presence and localization Ca2+ signaling molecules in mouse sperm. In 







4.2 Results  
4.2.1 Presence and Localization of the CatSper Channel in Mouse Sperm 
As a part our work in this chapter, we further validated the presence and 
localization of CatSper channel in mouse sperm by Western blot and 
immunofluorescence. Using antibody against CatSper 1 (D-17), we showed presence of 
expected molecular weight ~82 KDa protein in CatSper1 +/- mouse sperm lysates and that 
band disappeared in CatSper -/- mice. In addition, two additional bands ~150 KDa, and 
~37 KDa appeared in sperm from CatSper1 +/- mice and were completely lost in CatSper1 
-/- mice suggesting the detection of other CatSper isoforms in CatSper1 +/- mice. It has 
been shown that the expression and localization of other components of the CatSper 
complex is disrupted in CatSper1 null mice14.  Consistent with previous findings, we 
showed localization of CatSper 1 to the sperm principal piece of CatSper1 +/- mice and 
that signal disappeared in CatSper1 -/- mice suggesting that CatSper D-17 antibody is 
specific for CatSper 1 (Figure 4.1).  
4.2.2 Presence and Localization of Ca2+ Signaling Molecules in Sperm 
Ca2+ plays an essential role in sperm capacitation. In the absence of Ca2+, sperm 
fails to hyperactivate and cannot undergo acrosomal exocytosis. At the molecular level 
Ca2+ activates two parallel pathways associated to sperm capacitation. On one hand, 
Ca2+ positively promotes cAMP synthesis by direct stimulation of sAC; on the other hand, 
Ca2+ binds with calmodulin (CaM), which activates phosphodiesterase (PDE) and 
promotes cAMP degradation 19,64,171,172. In addition, Ca2+/CaM also directly stimulates 




capacitation is not well understood. As a  part of our work in this chapter, using specific 
antibodies against these Ca2+ signaling domains, we demonstrated their presence and 
localization in sperm. Western blot analysis using a CaMKII antibody detected ~50 KDa 
protein in both human and mouse sperm (Figure 4.2 and Figure 4.3, left panel). 
Consistent with the finding that CatSper structurally organizes CaMKII and other Ca2+ 
signaling in the sperm principal piece, we demonstrated similar precise localization of 
CaMKII in both mouse and human sperm (Figure 4.2 and Figure 4.3, right panel). 
Furthermore, immunoblotting with CaMKIV antibody in sperm lysates detected two 
distinct bands at 60 KDa and 32 KDa (Figure 4.4A). The antibody detected a 60 KDa 
protein at the expected molecular weight, however, the detection of a 32 KDa protein 
suggested the presence of other CaMKIV isoforms. The genome of Camk4 gene harbors 
three promotor regions. Transcription of the first two promotors give rise to two CAMKIV 
isoforms; α and β, while the third promotor located on the 10th intron position of Camk4 
genome gives rise to calspermin, a Ca2+/CaM-dependent protein134,142. Interestingly, a 
previous study used anti-calspermin antibody to detect its presence in various tissue 
lysates including testis and brain. Their results showed presence of a 63 KDa protein in 
brain and testis lysates, however, the 32 KDa protein detection was only restricted to the 
testis. This indicate that the lower band found in the sperm when using CaMKIV antibody 
could be calspermin. To investigate this hypothesis, we performed western blot analysis 
on mouse brain, testis and sperm lysates using CaMKIV antibody. Consistent with 
previous findings, we showed detection of CaMKIV in all the tissues but the 32 KDa 
protein was only restricted to the testis and sperm (Figure 4.4B). Moreover, unlike 




human sperm, suggesting a unique regulation of CaMKII and CaMKIV in sperm 
physiology (Figure 4.4C and Figure 4.5).  Using antibody against CaM, we showed a 
single 17 KDa protein in both human and mouse sperm (Figure 4.6, left panels). 
Consistent with its detection in sperm lysates, immunofluorescence (IF) assay showed its 
localization to the entire sperm flagellum and not in the head (Figure 4.6, right panel). 
 
4.2.3 Solubility Analysis of Ca2+ Signaling Molecules in Mouse Sperm 
Sperm is a highly compartmentalized cell that consist of a head and a tail. The tail 
portion also known as sperm flagellum consists of; mid-piece, principal piece, and an end 
piece. At the subcellular level, the sperm tail is further organized concentrically into three 
regions; plasma membrane, peri-axoneme, and axoneme37. The sperm plasma 
membrane forms the usual classic bilayer layer of glycolipids, glycoprotein, lipid rafts and 
ion channels182. Similarly, the peri-axonemal region which is composed of two structural 
units; the outer dense fibers (ODFs) and the fibrous sheath (FS), separates the axoneme 
from the plasma membrane. To add on this structural complexity, the sperm axoneme is 
further arranged into a 9+2 structural arrangement of microtubules, in which a central pair 
of singlet microtubules is surrounded by nine doublet microtubules (Figure 2.13)37.  
To investigate subcellular localization of various Ca2+ signaling domains, we 
performed solubility analysis on the sperm proteins obtained from CatSper1 +/- and 
CatSper -/- mice. The hypothesis behind using CatSper null mice was to understand the 
subcellular localization of downstream Ca2+ signaling domains in the absence of 




cytoplasmic, membrane and nuclear proteins, we demonstrated the presence of 
CatSper1, an initially identified membrane associated Ca2+ channel13, exclusively in the 
sperm insoluble fraction (pellet) (Figure 4.7) Consistent with the hypothesis that CatSper 
organizes other Ca2+ domains including CaMKII and calcineurin, CaMKII was also 
exclusively found in the insoluble fraction. Moreover, unlike CaMKII and CatSper1, 
calcineurin was found to be present in both soluble (supernatant) and insoluble fractions 
suggesting that calcineurin localizes both in the sperm plasma membrane as well as in 
the sperm axoneme. Since calcineurin also binds firmly to the dynein ATPase, its 
presence in the insoluble fraction was expected126. Similarly, CaMKIV was also present 
in both fractions suggesting its unique regulation from CaMKII. To our surprise, even 
though CaM was known to be highly soluble, it is only detected in the insoluble sperm 
fraction (Figure 4.7). Though super-resolution imaging of CaM suggested its localization 
more concentrated in the sperm axoneme and only some tethered at the peripheral region 
of sperm flagellum14.  
To investigate if the solubility status of any of the Ca2+ signaling domains changes 
in the absence of extracellular Ca2+, solubility analysis was performed on the sperm 
lysates from the CatSper -/- mice. Our results showed no change in the solubility status of 
these molecules (Figure 4.7) Nonetheless, immunofluorescence analysis revealed 
precise localization of PP2B in the sperm flagellum of CatSper +/- mice, but that signal 
was diminished and if present were randomly distributed through the sperm flagellum in 
the CatSper -/- mice (data not shown). Furthermore, to ensure that sperm proteins were 
well extracted, solubility analysis was performed with antibodies against tubulin and 




cytoskeleton bound protein appeared in the insoluble fraction, and phosphorylated form 
of hexokinase being highly soluble protein appeared mostly in the soluble fraction (Figure 
4.7).  
4.2.4 Regulation of CaMKII during Mouse Sperm Capacitation 
CaMKII is a multifunctional Ser/Thr kinase involved in several biological process 
such as cell apoptosis, memory and cardiac ion channel function. It exists as a 
holoenzyme composed of 12 subunits, where each subunit consists of an N-terminal 
catalytic kinase domain, a regulatory domain, a variable linker domain, and a C-terminal 
association domain129. Upon Ca2+/CaM binding to the regulatory subunit, the enzyme 
undergoes conformational change and auto-phosphorylates threonine residue (Thr) at 
position 286 (Thr286). Once phosphorylated at Thr286, CaMKII is autonomously 
activated independent of Ca2+/CaM. Activated CaMKII has much more affinity for 
Ca2+/CaM and its activity is significantly enhanced upon further stimulation by 
Ca2+/CaM131.  
Previous reports demonstrated the significance of CaMKII in CatSper null mice 
where disruption of CatSper channel resulted in delocalization of the phosphorylated form 
of CaMKII (pThr286)14. This suggested that Ca2+ entry mediated through CatSper channel 
is important for localized CaMKII signaling. Nonetheless, how and what regulates CaMKII 
during sperm capacitation is not clear. In this part of our work, we showed that 
phosphorylation of CaMKII decreases with capacitation time. When sperm were 
incubated in a media that supports capacitation (contains HCO3-, BSA, and Ca2+), CaMKII 




15 min. Then after 15 min of capacitation, phosphorylation of CaMKII gradually decreased 
until reaching levels comparable to the sperm incubated under non-capacitated sperm at 
60 min of capacitation (Figure 4.8A). These results indicate that phosphorylation of 
CaMKII remains basal when not capacitated, which then immediately increase upon 
exposure to capacitating conditions and then decreases to its basal levels (Figure 4.8A). 
Furthermore, CaMKII is a Ca2+/CaM-dependent kinase, to investigate if its activity is solely 
dependent on extracellular Ca2+, sperm were capacitated for 60 min in the presence of 
Ca2+, no added Ca2+ ([Ca2+]free), or [Ca2+]free in the presence of EGTA. Incubation of sperm 
in [Ca2+]free decreased the levels of CaMKII phosphorylation at 5 min of capacitation. In 
addition, [Ca2+]free +EGTA completely abrogated CaMKII phosphorylation (Figure 4.8B). 
These results indicate that regulation of CaMKII during of sperm capacitation is 
completely dependent on extracellular Ca2+ and not on other intracellular Ca2+ stores.  
4.2.5. Role of CaMKII in Capacitation Associated events 
Even though early work from the group of Ignotez and Suarez demonstrated the 
involvement of CaMKII in hyperactivation of bovine sperm183, mechanisms on CaMKII 
participation in mouse sperm capacitation are not well studied. To investigate this 
process, we used the selective inhibitor of CaMKII, KN-93.  Incubation of sperm with KN-
93 under capacitating conditions inhibited PKA substrate phosphorylation when probed 
with pPKAS antibody. Furthermore, to investigate if inhibition of PKA-substrates 
phosphorylation is an off-target effect of KN-93 on PKA, we used exogenous db-cAMP to 
directly activate PKA. Incubation of sperm in the presence of KN-93 and db-cAMP 
completely recovered the PKA-substrates phosphorylation that was inhibited by KN-93 




kinase activity radioactive assay. Our results confirmed that KN-93 does not inhibit 
directly the activity of PKA as PKA activity in the presence of KN-93 together with cAMP  
did not inhibit PKA activity (Figure 4.9B). To further confirm these results, we performed 
similar experiments using a highly specific peptide inhibitor of CaMKII, CaMKIINtide. 
Consistently, the peptide inhibitor also inhibited PKA-substrates phosphorylation, which 
then was recovered in the presence of db-cAMP (Figure 4.9C) and did not inhibit sperm 
PKA activity in the presence of cAMP (Figure 4.9D).To investigate if CaMKII regulates 
the physiological function of sperm, we performed analysis on sperm motility by computer 
assisted sperm analysis (CASA). Incubation of sperm with KN-93 during sperm 
capacitation did not affect the overall sperm motility or the percentage of sperm 
progressive motility out of the total motile (Figure 4.10A and B, respectively). However, 
incubation of sperm with KN-93 during sperm capacitation significantly decreased the 
percentage of sperm hyperactivation (Figure 4.10C) Consistent with western blot 
analysis, addition of db-cAMP in the presence of KN-93 recovered the inhibited sperm 
hyperactivation (Figure 4.9). These results indicate that CaMKII activation is required for 
the acquisition of hyperactive motility during sperm capacitation. 
4.3 Conclusion 
Role of Ca2+ in capacitation process in indispensable. At the molecular level, Ca2+ 
regulates this event through two parallel pathways, one by promoting cAMP synthesis by 
activating sAC and other by degrading cAMP by activating PDE through Ca2+/CaM 
binding3,10,19. Besides regulating cAMP metabolism, Ca2+ or Ca2+/CaM is important for 
activation of downstream kinases and phosphatases, whose role in sperm capacitation 




the principal Ca2+ channel in sperm, and the mice lacking functional CatSper channel 
failed to hyperactivate and are infertile both in vivo and in vitro11–14. The inability of 
CatSper null mice to fertilize metaphase II eggs was attributed to the aberrant/premature 
P-Tyr of sperm axonemal proteins when incubated under capacitating conditions14. Yet 
the role of Ca2+/CaM-dependent kinases such as CaMKII, CaMKIV and CaM in this 
process is not understood.  
As a part of our work in this chapter, we first characterized the presence and 
localization of these Ca2+signaling molecules in sperm and demonstrated the importance 
of significance of CaMKII in sperm capacitation. Using specific antibodies, we 
demonstrated their presence in mouse (CatSper, CaM, CaMKII, CaMKIV, and PP2B) and 
human sperm (CaM, CaMKIV, CaMKII). To investigate their localization, we performed 
immunofluorescences assays in mouse (CatSper, CaM, CaMKII, CaMKIV, and PP2B) 
and human sperm (CaMKII and CaMKIV).  While the localization of PP2B, CatSper, and 
CaMKII was expected to be present in the principal piece of sperm flagellum, as they 
together form a Ca2+signaling domain organized by CatSper, the localization of CaMKIV 
in the sperm midpiece was completely unexpected. Yet the precise localization of 
CaMKIV in midpiece suggest its unique regulation in sperm physiology from CaMKII and 
other Ca2+ signaling molecules. Furthermore, to understand the subcellular localization of 
these signaling molecules, solubility analysis on the sperm lysates from CatSper1 +/- and 
CatSper -/- mice were performed. The hypothesis behind using CatSper null mice was to 
see the effect of the absence of extracellular Ca2+ on these signaling molecules. Solubility 
analyses revealed unexpected subcellular localization of CatSper and CaMKII in sperm 




a functional Ca2+ channel. Similarly, CaM being soluble, universal Ca2+ adaptor protein, 
it was expected to be found in soluble fraction, however, we identified CaM in sperm 
axoneme. Detection of CaM in sperm axoneme was somewhat expected as super-
resolution imaging of CaM also suggested its localization in sperm axoneme as well as in 
peripheral region of sperm flagellum14. Moreover, consistent with the unique localization 
of CaMKII (principal piece) from CaMKIV (midpiece), CaMKIV was found in both sperm 
axoneme as well as in sperm plasma membrane. Similar to CaMKIV, PP2B was also 
distributed in sperm pellet as well in sperm plasma membrane. In these experiments, 
control for efficient lysis were performed by immunoblotting sperm protein lysates with 
tubulin (found abundantly in sperm pellet) and pY antibodies (detects highly soluble 
phosphorylated for of hexokinase). 
To investigate the regulation of CaMKII in sperm capacitation, we used antibody 
that specifically recognizes  the phosphorylated form of CaMKII (pThr286)14. When sperm 
were incubated in a media that supports capacitation, CaMKII became rapidly 
phosphorylated (in 1 min) and maintained its phosphorylation status until 15 min. Then 
after 15 min of capacitation, phosphorylation of CaMKII gradually decreased until 
reaching levels comparable to the sperm incubated under non-capacitated sperm at 60 
min of capacitation. Furthermore, to evaluate the dependence of CaMKII in extracellular 
Ca2+, sperm were capacitated in a media that is devoid of Ca2+ or in the media that lacked 
Ca2+but contained EGTA to further chelate Ca2+ in the media. Incubation of sperm in such 
capacitating condition decreased CaMKII phosphorylation that is dependent of 
Ca2+availability.  




this process, we used two specific inhibitors of CaMKII, KN-93 and CaMKIINtide. 
Incubation of sperm with these under capacitating conditions inhibited PKA substrate 
phosphorylation when probed with pPKAS antibody. Furthermore, to investigate if 
inhibition of PKA-substrates phosphorylation is an off-target effect of KN-93 on PKA, we 
used exogenous db-cAMP to directly activate PKA. Incubation of sperm in the presence 
of KN-93 and db-cAMP completely recovered the PKA-substrates phosphorylation that 
was inhibited by KN-93 or CaMKIINtide alone (Figure 4.9A). These results were further 
verified in in vitro kinase assay, where PKA activity was not affected when noncpaciated 
sperm lysates were incubated in the presence of db-cAMP along with CaMKII inhibitors. 
Finally, to investigate the role of CaMKII in sperm physiology, sperm were capacitated in 
the presence of KN-93 and sperm motility analysis was performed by CASA system. 
CASA analysis revealed significant reduction in the percentage of hyperactivated sperm 
but did not affect the percentages of overall sperm motility. Consistent with western blot 
analysis, inhibition of hyperactivated motility was recovered when sperm were incubated 
with db-cAMP in the presence of KN-93. These findings suggested that CaMKII is 
involved in the regulation of both biochemical and physiological aspects of sperm 
capacitation. 
In this work we provided the evidence for the involvement of CaMKII in sperm 
capacitation. Nonetheless, there are other Ca2+ signaling molecules whose regulation and 
involvement in fertilization process is completely unknown. As a preliminary data, we 
presented here the evidence of their presence in mouse and human sperm, but for the 
functional role of these molecules, development of phopho-specific antibodies, specific 












Chemicals and reagents were purchased from following sources: Bovine serum 
albumin (BSA, fatty free acid, cat. # A0281), sodium bicarbonate (NaHCO3) (cat. # S-
5761) sodium orthovandate (NaVO4) (cat. # S-6508), β-glycerophosphate (βGP) (cat. # 
G-9891), p-nitro phenyl phosphate (cat. # 4645) HEPES (cat. # BP310), 3-Isobutyl-1-
methylxanthine (IBMX, cat. # I5879), dibutyryl cAMP (db-cAMP, cat. # D0627), 
cyclosporin A (CsA, cat. # C3662), and Human Chorionic Gonadotropin (hcG) (cat. # 
CG5) were purchased from Sigma Aldrich (St. Louis, MO). Okadaic Acid (OA, cat. # 
10011490), Kemptide (cat. # 15555), H-89 (cat. # 10010556), FK-506 (cat.  # 10007965) 
were purchased from Cayman Chemical Company (Ann Arbor, MI). Calyculin A (cat. # C-
3987) was purchased from LC Laboratories (Woburn, MA). Protease inhibitor cocktail 
tablets (cat. # 11697498001) Roche (Indianapolis, IN). Pregnant Mare Serum 
Gonadotropin (PMSG) (cat. # 493-10) was purchased from Lee Biosolutions (Maryland 
heights, MO), Fetal Bovine Serum-Heat inactivated (cat. # S11150-H) was purchased 
from Atlanta Biologicals (Atlanta, GA). Phospho-PKA Substrate (RRXS*/T*) (100G7E) 
rabbit monoclonal antibody (Cat. # 9624) purchased from Cell signaling (Danvers, MA). 
Primary antibodies PP2B-Aα (D-9) (Cat. # sc-17808), PP2B-Aβ (A-11) (cat. # sc-365612), 
PP2B-Aγ (M-17) (cat. # sc-6122), PP2B-B1/B2 (D-1) (cat. # sc-373803), FKBP12 (H-5) 
(cat.  # sc- 133067) were purchased from Santa cruz biotechnology (Dallas, TX). 




035-150) and anti-sheep IgG (cat. # 713-035-003) was purchased from Jackson 
ImmunoResearch Laboratories (West Grove, PA). Peroxidase- conjugated anti-rabbit IgG 
(cat. # NA934V) and ECL Prime (Cat. # RPN2236) Western blotting detection reagents 
were purchased from GE Healthcare (Pittsburgh, PA), Alexa Fluor 488-conjugated 
secondary anti-mouse antibody (cat. # A-11001) and Texas Red 555- conjugated anti-
goat secondary antibody (cat. # PA1-28662) were purchased from Invitrogen, Thermo 
Fisher Scientific (Waltham, MA). Kanamycin sulfate (cat. # 420311) was purchased from 
Millipore (Burlington, MA). [Isopropyl-β-D-thiogalactopyranoside] (IPTG) was obtained 
from Research Product International (IL). Ready-strip IPG strips (cat. # 163–200), Bio-
lyte R (3/10, 40%, pH range: 3.5–9.4) and sodium dodecyl sulfate (SDS) were purchased 
from Bio Rad (BioRad Laboratories, Hercules, CA). LRE1 (6-chloro-N4- cyclopropyl-N4-
(2-thienylmethyl)-2,4-pyrimidinediamine), a selective allosteric inhibitor of soluble 
adenylyl cyclase (sAC), was purchased from Nanosyn (Santa Clara, CA). Polyclonal His-
Tag rabbit antibody (cat. #2365S) was purchased from Cell Signaling (Danvers, MA). Two 






All mice were sacrificed in accordance with the guidelines approved by the 
Institutional Animal Use and Care Committee (IACUC), University of Massachusetts, 
Amherst. 
 





Mouse cauda epididymal sperm were collected from CD1 retired breeder male 
mice by the “swim out” method in TYH/Hepes medium as described previously [12]. The 
TYH/Hepes medium contained the following compounds (concentrations in parenthesis 
are given in mM): NaCl (100), KCl (4.7), KH2PO4 (1.2), MgSO4 (1.2), glucose (5.5), pyruvic 
acid (0.8), CaCl2 (1.7), HEPES (20). Mouse sperm capacitation was achieved by 
incubation in TYH/Hepes medium supplemented with 15 mM NaHCO3 and 5 mg/mL BSA 
for 1 h at 37◦C; TYH/Hepes medium with no additives served as noncapacitating medium. 
After washing in PBS, sperm pellets were either processed immediately or saved at –
80◦C. 
5.2.3 Differential Isotopic Labeling and Global Quantification of Phosphopeptides  
 
Procedures used for the identification of phosphopeptides and the quantification 
of the relative extent of phosphorylation on sperm proteins have been thoroughly 
described previously [8]. Briefly, extracts were prepared from sperm incubated in 
conditions that either support or do not support capacitation (see below) and subsequent 
trypsin proteolytic digestion was conducted as described [8]. Fisher esterification was 
carried out in either noncap and cap samples using methyl alcohol labeled with either 
hydrogen (d0) or deuterium (d3). At the end of the procedure, four distinct samples were 
obtained: noncap (d0), noncap (d3), cap (d0), and cap (d3). Differentially labeled aliquots 
of the dissimilar, esterified samples (i.e. noncap (d0 esters) and cap (d3 esters); or 
noncap (d3 esters) and cap (d0 esters)) were combined and subjected to IMAC. The 
IMAC precolumn was connected to an analytical reverse-phase HPLC column containing 
an integrated microelectrospray (ESI) emitter tip. Peptides were then gradient-eluted 




[8]. Phosphopeptide sequences were identified using the SEQUEST algorithm within 
Proteome Discoverer (ThermoFisher Scientific) and manually verified. Quantification of 
the relative extent of phosphorylation was done by calculating the ratio of the capacitated 
peptide peak (d0 esters) area to the corresponding noncapacitated peptide (d3 esters) 
peak area. This procedure was repeated with the alternatively labeled extracts, cap (d3 
esters) and noncap (d0 esters). Final values were calculated by taking the square root of 
the ratio of the two individual ratios, which served to compensate for potential systematic 
errors inherent in comparing the deuterated and the nondeuterated peptides. 
5.2.4 Sequence Alignment and Phylogenetic Analysis  
 
Using mouse Rspha6a gene as query, we searched for homologs in the ENSEMBL 
database (release 90) within chordates. Only sequences with complete coding sequences 
(CDS) were kept for further analysis, and aligned using CLUSTAL Omega at EMBLEBI 
[13, 14]. Sequences that did not start with an ATG codon or that had multiple ambiguities 
were discarded. Protein and nucleotide alignments were visually inspected using Wasabi 
web browser [15]. Protein conservation was analyzed using PlotCon 
(http://www.bioinformatics.nl/cgi-bin/emboss/plotcon), using the EBLOSUM62 
aminoacidic similarity matrix, with a window size of 100 residues to account for 
conservation in neighboring sites. Phylogenetic analyses were performed with MrBayes 
3.2.6 [16, 17] through the CIPRES Science Gateway [18] under the following parameters: 
using a GTR + InvGamma model with exponential and Dirichlet priors, performing two 
runs for 107 generations, sampling every 103 generations, and discarding the first 25% 
generations considered as the burn-in phase. The resulting consensus tree was 




5.2.6 In silico Rsph6a Phosphorylation Analysis  
 
We selected the human and mouse Rsph6a protein sequences as references and 
performed phosphorylation site predictions using three online tools: NetPhos 3.1 Server, 
pkaPS, and the GPS Web Server. The NetPhos 3.1 Server [25, 26] predicts serine, 
threonine, or tyrosine phosphorylation sites in eukaryotic proteins using ensembles of 
neural networks. Both generic and kinase-specific predictions can be performed with this 
tool. For our analysis, only scores above 0.9 were recorded. The pkaPS predicts the 
existence of PKA phosphorylation sites using a simplified kinase binding model [27].The 
GPS 3.0 [28] predicts protein phosphorylation sites and their cognate kinases, and is able 
to classify protein kinases into a hierarchical structure with four levels (including group, 
family, subfamily, and single protein kinase). The Netphos 3.1 Server was used to predict 
generic and kinase-specific phosphorylation sites, while pkaPS and GPS Web Server 
were applied to find PKAspecific phosphosites. 
5.2.7 Analysis of Mouse Rsph6a Expression by Quantitative PCR 
 
Quantitative PCR analysis on N-terminus region of Rsph6a gene was performed 
using the PerfeCtaR SYBR GreenR SuperMix, Low RoxTM cocktail (Quanta Biosciences, 
Gaithersburg, MD) and F4/R4 Rsph6a N-terminus oligonucleotide primers as described 
above. Reaction mixtures were assembled in 20-μL volume (3 ng cDNA and 500 nM 
primers) and incubated in a Stratagene MX300p qPCR system (Agilent Technologies, 
Santa Clara, CA). Conditions used for thermal detection consisted of initial denaturation 
at 95◦C for 3 min, followed by 40 cycles of 30 s denaturation at 95◦C, annealing at 56◦C 
for 45 s, and extension at 72◦C for 1 min. Dissociation curves were run simultaneously to 




contaminating DNA, and observed no additional peaks other than the desired single 
products. Conditions used to evaluate dissociation curves were 95◦C for 1 min, 55◦C for 
30 s, 95◦C for 30 s. Quantitative PCR analysis was performed on three biological 
replicates. For each biological replicate, reactions were run in triplicate. For normalization, 
analysis of a housekeeping gene (β-actin) was conducted in parallel with all tissues, and 
CT values for each reaction were collected and averaged as described before [20]. Then, 
CT values from mouse tissues were deduced from their corresponding β-Actin CT values 
and calibrated with CT values obtained from data obtained in 4-week-old mouse testis, 
and the 2ˆ-CT method was applied to report mRNA expression. Error bars indicate ± 
standard error of the means (±SEM). 
5.2.8 Molecular Cloning and Recombinant Protein Production 
 
 Two of the predicted full-length Rsph6a transcripts named I1 and I2 were amplified 
using Phusion R High-Fidelity DNA polymerase (New England Biolabs, Ipswich, MA) from 
100 ng cDNA synthesized from 8-week-old mouse testis tissues. Primers used to amplify 
both full-length cDNAs were F8- GGAATTCCATATGGGGGAACCACCGCCCAAT and 
R8- CCGCTCGAGGTCCTCCAGGTCTTCATCCTC (underlined sequences indicate the 
NdeI and XhoI restriction sites included in primers). The PCR products were then 
separated on 1.5% agarose gels and fragments (1369 and 2144 bp) were excised and 
purified using PrepEaseR Gel extraction Kit (USB Corporation, Cleveland, OH), and 
directly cloned into a pET-30a (+) expression vector containing a kanamycin-resistance 
gene and a C-terminal His-Tag sequence, as previously described [21]. For this purpose, 
common restriction sites containing PCR products and pET vector were digested, 




product or pET vector) with 10 units NdeI and XhoI in CutSmartTM Buffer (New England 
BioLabs) at 37◦C. Ligation reactions were performed at 14◦C overnight using Express 
Link TM T4 DNA Ligase (5 units) (ThermoFisher Scientific). For the production of the His-
tagged proteins, we followed a modified protocol [22]. A pET vector carrying Rsph6a 
inserts was transformed into T7 expression BL21 (DE3) Escherichia coli strain (NEB). 
After confirming insert sizes by colony PCR and sequencing (Genewiz, South Plainfield, 
NJ), BL21 cells were grown overnight at 37◦C in a shaking incubator (250 rpm) in LB broth 
containing 100 μg/mL kanamycin. After cultures had reached the desired optical density 
(OD) of 0.61, protein expression was induced with 1 mM IPTG for 4 h at 37◦C with 
constant shaking. Cells were then harvested at 14,000 rpm for 15 min, and cell pellets 
saved at –80◦C for later analysis by western blotting. Probe design and in situ 
hybridization. 
5.2.9 Probe Design for in situ Hybridization  
 
RNA probes (antisense and sense) were designed for Rsph6a testis-specific N-
terminus analysis by in situ hybridization; Tssk6 amplimers were used as control. 
Complementary DNA from mouse testis (100 ng) was amplified with F (antisense)- 
TCTTCCATTTCCTGTTCGCC, R(antisense)-TAATACGACTCACT 
ATAGGGTCTTCCATTTCCTGTTCGCC and F(sense)- TAATAC 
GACTCACTATAGGGCAGCACGGACCCTACCTGAG, R(sense)- 
TCTTCCATTTCCTGTTCGCC for Rsph6a and F (antisense)- 
AAACTCCTGAGCGAACTTGG and R (antisense)- TAATACGACT 
CACTATAGGGACCGAAATCCGTGATCTTGA for Tssk6. In vitro transcription and 




minor modifications. After probe hybridization, tissue sections were washed, treated 
with blocking solution, and incubated with anti-Digoxigenin-AP (Fab fragments antibody, 
Roche). After color development by incubation with BM Purple AP substrate (Roche), 
slides were prepared for mounting in Cytoseal-60 (ThermoFisher Scientific). 
5.2.10 Custom-made Rsph6a Antibodies  
 
Two mouse monoclonal antibodies against Rsph6a were generated by Abmart 
(Shanghai, China). Briefly, Rsph6a protein sequence was subjected to a proprietary 
algorithm analysis (SEALTM method) to identify two 12-residue fragments (E2: 
PSQTRRASQGSE; E3: QRGSRSSQGSQD) with the highest “epitope score” in the N- 
terminus region of Rsph6a protein. These antigenic sequences were then used to 
immunize Balb/c mice to generate hybridoma cells after fusion of splenocytes with a 
selected myeloma cell line. After subcloning (2–4 rounds) of these hybridoma cells, 
positive subclones selected by ELISA screening were injected into mouse peritoneal 
cavity for production of ascites fluid. Ascites were then purified for each antibody, and 
mAb E2 and mAb E3 (corresponding to E2 and E3, respectively) were selected and 
further characterized for their ability to recognize recombinant Rsph6a isoforms by 
western blotting. 
 
5.2.11 Rsph6a Protein Extraction and Solubility Analysis  
 
To analyze Rsph6a solubility, aliquots of approximately 1-2 million sperm were 
suspended in noncapacitating media. After 15 min, sperm were centrifuged at 10,000 × 
g for 5 min. Sperm pellets were then resuspended in a buffer containing: Tris/HCl 40 mM 
pH 7.5, complete protease inhibitor cocktail (Roche), and 1 % Triton X-100. This 




Supernatants were kept for western blot analysis and pellets were resuspended in 
nonreducing SDS sample buffer (without added β-mercaptoethanol or DTT), boiled for 5 
min, and centrifuged. The resulting supernatant was kept for western blot analysis. In an 
independent experiment, sperm pellets were directly suspended in nonreducing sample 
buffer, boiled for 5 min, and then centrifuged. Supernatants were kept for western blot 
analysis and the sperm pellet boiled once more in nonreducing sample buffer. After 
centrifugation at 10,000 × g, supernatants were saved for western blot analysis and the 
resulting pellet was suspended in reducing sample buffer containing 50 mM DTT and 
boiled once more for 5 min. After centrifugation, the supernatant was saved for western 
blotting analysis. 
5.2.12 SDS-PAGE and Western Blot Analysis 
 
Sperm pellets obtained from various experimental conditions were lysed in 
Laemmli sample buffer without added β-mercaptoethanol (BME). Samples were then 
boiled for 5 min, centrifuged and supernatants were collected. Sperm proteins from the 
supernatant were then further denatured by boiling for 5 min in the presence of 5% β-
mercaptoethanol. After brief centrifugation, protein extracts equivalent to 1–2 × 106 
sperm per lane were subjected to SDS-PAGE gel. Separated proteins were then 
transferred to PVDF membrane (Millipore), blocked with 5% dry fat-free milk in TBS 
containing 0.1% Tween 20 (T-TBS). Membranes were incubated with various primary 
antibodies (1:1000) in 1% milk overnight at 4°C with gentle agitation. While probing by 
phospho PKA substrate antibody (1:10,000), antibody dilutions was prepared in 5% BSA 
(Sigma, cat. #A7906). After incubation with primary antibodies, membranes were washed 




(1:10,000 dilutions from a 0.8μg/ mL stock concentration). Protein detection was 
performed by ECL prime, an enhanced chemiluminescence kit (GE Healthcare). When 
necessary membranes were stripped with stripping buffer at 55°C for 20 min. Stripping 
buffer contained the following components 2% SDS, 0.74% β-mercaptoethanol, 62.5 mM 
Tris, pH 6.5. Following stripping membranes were rinsed several times with distilled H2O, 
blocked and probed with anti-tubulin antibody (1:2000 dilution, clone E7) for loading 
control (University of Iowa Hybridoma Bank). 
5.2.13 Two-dimensional Gel Electrophoresis (2D-PAGE) and 2D Western Blotting  
 
Sperm pellets (equivalent to 4–6 × 106) were lysed in nonreducing sample buffer, 
boiled, centrifuged, and supernatants were removed, as described above, to eliminate 
significant amount of proteins. Subsequently, the remaining pellet was resuspended in 
rehydration buffer containing 8M urea, 2M thiourea, 4% CHAPS, 20 mM DTT, 0.5% (w/v) 
Bio-LyteR 3/10 ampholytes, and 0.001% bromophenol blue for 30 min in a slow rocking 
shaker at room temperature as previously described [24] with slight modifications. Briefly, 
after complete solubilization of sperm pellets, 7-cm IPG strips (pI 3–10, BioRad) were 
passively rehydrated for 16 h at RT. Isoelectric focusing (IEF) of IPG strips was then 
performed in a PROTEAN IEF Cell (Bio-Rad) in six steps as follows: 50 V for 15 min 
(linear), 100 V for 15 min (linear), 150 V for 15 min (linear), 250 V for 15 min (linear), 4000 
V for 2 h (linear); the final focusing step was maintained for 24,000 Vh. After completion 
of IEF, equilibrated IPG strips were briefly rinsed in SDS running buffer, and subjected to 
the second dimension, SDS-PAGE, as described above. Once completed, gels were 
transferred to PVDF membranes and western blotting conducted with anti-Rsph6a 






Indirect immunofluorescence analysis was performed as previously described [20]. 
Briefly, sperm samples were collected in TYH/Hepes buffer and washed gently. Cells 
were then pipetted onto polylysine coated coverslips, air-dried, and permeabilized with 
0.5% Triton X-100 in PBS. Following washings and blocking for nonspecific binding, 
incubation with various antibodies in 3% BSA was done overnight at 4◦C, followed by 
incubation with Alexa-488-conjugated various secondary antibodies (1:200 in 3% BSA) 
(ThermoFisher Scientific (Invitrogen)). Coverslips were thoroughly washed and mounted 
onto slides using Vectashield-H1000 mounting solution (Vector Laboratories, Burlingame, 
CA). Immunofluorescence images were acquired with a Nikon Eclipse TE300 
fluorescence microscope (Melville, NY). 
5.2.15 Measurement of PKA Activity 
 
PKA activity was measured as described previously. Briefly, triton-insoluble 
fraction of sperm incubated under non-capacitating condition was used as the source of 
PKA. To measure activity of PKA, a synthetic Kemptide that carries phosphorylation site 
of PKA (H-Leu-Arg-Ala-Ser-Leu-Gly-OH) was used as its specific substrate. Insoluble 
fraction of sperm (108cells) was prepared by lysing sperm pellet in a buffer containing 1% 
Triton-X, 10μM leupeptin, 10μM aprotinin, and 25mM Hepes, pH 7.2. After cell lysis, 
soluble fraction was separated and resulting pellet was resuspended in a resuspension 
buffer containing100μM IBMX, 10μM leupeptin, 10μM aprotinin, and 25mM Hepes, pH 
7.2. PKA kinase assay was initiated by adding 10 μL (per assay) of this insoluble fraction 
with 10μL of 3X kinase buffer (40μM ATP, 1μCi [Υ-32P] ATP, 10mM MgCl2, 10μM 




βGP, 1% triton, 1mg/mL BSA, and 100μM IBMX) adjusted with necessary inhibitors or 
controls in a 30μL final reaction volume for 30 min at 30°C. After incubation, the reactions 
were stopped by adding 20μL of 40% tricholoro acid solution (TCA), cooled on ice for 20 
min and centrifuged for 3 min at 10,000×g. Thirty microliters of the resulting supernatants 
were then spotted onto phosphocellulose papers (2×2 cm)(Whatman P81), washed 4×10 
min in 5mM orthophosphoric acid followed by a final washing in ethanol for 10 min. 
Washed phosphocellulose papers were then dried and placed in vials containing 2.5 mL 
scintillation fluid and PKA activity was recorded as counts per minute (CPM) in a 
scintillation counter (Beckman). Each kinase assay was run in triplicate and was repeated 
at least 3 times.  
5.2.16 Extraction and Measurement of cAMP Levels in Sperm 
 
 Preparation of sperm lysates for cAMP extraction was performed as described 
previously. Briefly, sperm pellets obtained from 4×106 cells incubated in various 
experimental conditions (Ncap, Cap, Cap media supplemented with various inhibitors) in 
the presence or absence of 100μM IBMX were lysed in 40μL lysis buffer (1% triton-X, 1X 
EDTA free protease inhibitor cocktail, 100μM IBMX, and 25mM Hepes, pH 7.2) in ice for 
30 min. Sperm lysates were then boiled for 10 min to inactivate sperm enzymes and 
supernatants were collected by centrifugation (13,4000 rpm for 5 min). Ten microliters of 
the supernatant that contained unknown amounts of cAMP was then used to activate 
sperm PKA in 30μL kinase reaction as described above. To measure exact amount of 
cAMP levels, known concentrations of cAMP were run on parallel to generate standard 




was then used to determine sperm intracellular cAMP concentrations from unknowns 
PKA activity by interpolation.  
5.2.17 Sperm In Vitro Cyclase Assay 
 
1x107 non-capacitated sperm were washed two times by centrifugation (2000xg, 5 
min) with 40 mM Tris pH 7.4, 140 mM NaCl. The pellet was resuspended in 200μL lysis 
buffer containing 40 mM Tris pH 7.4, 140 mM NaCl, 1% (v/v) Triton-X, mPIC (1:100) and 
incubated on ice for 30 min. Lysates were centrifuged for 10 min at 10.000xg and the 
supernatant was transferred to a fresh tube. The in vitro cyclase assay was performed 
with 50μL sperm lysate in 100μL total reaction volume containing 50 mM Tris pH 7.5, 3 
mM DTT, 20 mM Creatine Phosphate, 10 mM MgCl2, 100 U/ml CPK, 2mM ATP, [α32P] 
ATP. For activating sAC, 10 mM CaCl2 and 30 mM NaHCO3 were added. Additionally, 10 
μM cyclosporine A or DMSO as control were included in the assay. After incubating the 
reaction mix for 30 min at 30 °C, the reaction was stopped by adding 200μL 2% (w/v) 
SDS. Adenylyl cyclase activity was determined by measuring the conversion of [α32P] 
ATP to [32P] cAMP. [32P] cAMP levels were determined using the previously described 
two-column method (Levin LR, et al. Cell 1992; 68:479–489).  
5.2.18 Computer Assisted Sperm Analyses (CASA) 
 
Sperm motility analysis was conducted by CASA system. After completion of 
capacitation, 30 μL sperm suspensions were loaded into pre-warmed chamber slide 
(depth, 100 μm) (Leja slide, Spectrum Technologies) and placed on a microscope stage 
set at 37 ºC. To assess sperm motility, CEROS computer-assisted semen analysis 
(CASA) system (Hamilton Thorne Research, Beverly, MA) as previously described 




frame rate: 60 Hz; minimum cell size: 4 pixels; static head size: 0.13-2.43; static head 
intensity: 0.10-1.52; static head elongation: 5-100. Evaluation of sperm that are 
hyperactivated as a result of capacitation process was conducted by CASAnova software 
(Goodson et al., 2011). For each experimental condition, at least 5 microscopy fields 
containing minimum of 200 sperm were analyzed.  
5.2.19 Mouse Eggs Collection and In vitro Fertilization (IVF) 
Metaphase II- arrested mouse eggs were collected from 6-8-week-old super 
ovulated CD1 females (Charles River Laboratories). Females were super ovulated by 
injecting 5-10 IU pregnant mare serum gonadotropin (PMSG) followed by 5-10 IU human 
chorionic gonadotropin (hCG) 48 hrs later. Thirteen hours after hCG injection, females 
were scarified, and cumulus-oocyte complexes were collected in TL-Hepes. After 
washing cumulus-oocyte complexes (COCs) with already equilibrated (5% CO2 at 37 °C) 
TYH media, two of them (containing ̴ 30-40 eggs) was transferred to the dish containing 
a 90μL droplet of TYH media covered with mineral oil. Fertilization drops containing COCs 
were then inseminated with capacitated sperm at a final concentration 1-2 × 105 cells/mL 
(control condition). Other experimental conditions consisted: 1) pre-incubation of the 
sperm with 10μM CsA  during capacitation; 2) pre-incubation of the COCs with 10μM ; 
and 3) pre-incubation of sperm with 10μM CsA plus addition of the drug to the 
insemination drop (10μM CsA was present during the 4 hrs allowed for fertilization).  
After 4 hrs of insemination, eggs were washed by transfer them to fresh TYH media 
in adjacent droplets. Fertilization was evaluated by counting the number of 2-cell embryos 
after 24 hrs of insemination. Results are expressed as % of 2-cell embryos out of the 





5.2.20 Statistical Analysis  
 
Statistical analysis was performed using the GraphPad Prism version 8.2.1 
software. Data presented here are the means ± SE of at least three independent 
experiments, each performed in triplicates. Ordinary one-way ANOVA followed by 



























Table 1.1 In silico prediction of Rshp6a phosphorylation sites by PKA. Total phosphosites 
predicted by Netphos 3.1, and PKA-specific phosphorylation sites predicted with pkaPS 
and GPS, in human RSPH6A (left) or mouse Rsph6a (right). Gray boxes indicate 














Figure 1.1 Schematic diagram of the cross section of seminiferous tubules. Shown on 
diagram are the developing germ cells. As the germ cells mature, they progress towards 



















Figure 1.2 Schematic of mammalian sperm axoneme. Shown on the diagram is 9+2 
microtubule arrangement found in the principal piece of sperm flagella. Image adapted 












Figure 1.3 Sperm acrosome reaction. (A). Schematic diagram showing fusion of 
acrosome reacted sperm with the egg in the perivitelline space. Numbers represent 
possible site of acrosome reaction (B) After mobilization of internal calcium stores, the 
previously intact golgi-derived organelle “acrosome” fuses with sperm plasma membrane 
and undergoes acrosomal exocytosis, a prerequisite mechanism for sperm egg fusion. 










































Figure 1.4 Molecular basis of sperm capacitation. (fast event) As soon as the sperm 
comes in contact with the media containing Ca2+ and HCO3-, soluble adenyl cyclase (sAC) 
is activated, which then synthesizes cAMP and activates PKA. Activation of PKA 
immediately (within 30 sec) activates downstream PKA substrates by phosphorylation 
and starts a vigorous sperm motility known as activated sperm motility. After extended 
incubation of sperm (slow event) in the presence of Ca2+, HCO3-, and BSA, activated PKA 
pathway further initiates activation of downstream signaling cascades, which then leads 
to the phosphorylation of tyrosine residues (P-Tyr) of several sperm axonemal proteins. 
P-Tyr of sperm axonemal proteins modulates sperm motility pattern from activated motility 
to hyperactivated motility, which then prepares sperm to undergo acrosomal exocytosis 
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Figure 2.1 Enrichment of Rsph6a phosphopeptide in capacitated mouse sperm. Single 
ion chromatograms for the differentially labeled phosphopeptide RApSQGpSeR from (A) 
the d0 capacitated/d3 noncapacitated analysis and (B) the d3 capacitated/d0 
noncapacitated analysis. Predicted monoisotopic masses for the ions of type b and y are 
shown above and below the sequences, respectively. Ions observed in the associated 
MS/MS spectrum are underlined and those that lose phosphoric acid are presented in 
bold type. The label “Δ” denotes loss of phosphoric acid from the corresponding ion of 
type b or y. “R-OMe” represents the Fisher esterified C-terminal arginine, while “e” 
represents the Fisher esterified glutamic acid. Masses for b and y ions, which are shifted 
by +3 amu in the deuterated spectra, are presented in blue, while those ions shifted by 
+6 amu are presented in red. The Cap/NCap ratio for each analysis (11.44 in experiment 
A and 7.94 in experiment B) was used to calculate an overall odds ratio of 9.53, in order 
to remove potential errors associated with the comparison of the deuterated and 
nondeuterated peptide species [8]. Spectra shown are representative of at least three 








































Figure 2.2 (A) Rsph6a isoform 1 and isoform 2 amino acid sequences. Antibodies 
epitopes are underlined in each isoform (E2 or E3). The sequence corresponding to the 
phosphopeptide detected by MS/MS is shown in red, boldface, and larger font. (B) 
Chordates phylogeny showing the origin of mammalian RSPH6A and RSPH4A. The 
chordates common ancestor had one RSPH gene (indicated as ancestral RSP), which 
was duplicated along the Therian (marsupials and placental mammals) branch. Each 
copy acquired an extra N-terminus. Within placentals, one copy retained the canonical 
function (RSPH4A) while the other is tissue specific (RSPH6A) as a result of a 
neofunctionalization process. In marsupials, RSPH6A is no longer a functional gene as a 








































Figure 2.3 Phylogenetic analysis of radial spoke proteins. (A) Bayesian phylogenetic tree 
of a total of 91 RSPH coding sequences, representing all major chordates groups. 
Branches derived from nodes with posterior probability values under 0.7 are shown in 
light gray, while black branches depict nodes with posterior probabilities equal or over 
0.7. The RSPH sequence of Ciona was set as outgroup. In Eutherian mammals RSPH4a 
and a produce two reciprocally monophyletic subtrees, reflecting a duplication event that 
can be traced back to the Therian ancestor (see http://wasabiapp.org:8000/?id=i0mphn). 
Marsupial RSPH6a sequences were excluded in this analysis due to coding sequence 
degeneration. The interactive version of the tree has been uploaded to the iTOL server 
(https://itol.embl.de/tree/2001689155162511505223012). (B) Phylogenetic tree 




representative of a duplication event; white boxes are representative of the loss of one 
copy. Representation of Rsph4a and Rsph6a exons is separated by space. White blocks 
are representative of 5'UTR and 3'UTR regions. Blocks in either red, blue, green, 
magenta, ochre, or cyan correspond to homologous codifying regions of exons 1, 2, 3, 4, 
5, and 6 of the mouse Rsph4a protein. The yellow block represents the region of exon 1 
from Rsph6a, conserved in all placental mammals. Gray blocks represent regions without 
homology using the ORF of mouse Rsph4. The asterisk (*) indicates partial homology of 
these exons with their respective mouse ones. Long exons are indicated with a double-



















































































Figure 2.4 Analysis of the amino acid sequence homology between full-length mouse 
Rsph4a and Rsph6a. Red residues indicate conserved amino acids, which are signalized 
with an asterisk (*), while blue ones indicate amino acid similarity, and are signalized with 
a dot (.). Gray shaded region indicates Ca2+/calmodulin-predicted binding site for Rsph6a 































Figure 2.5 Conservation plot. Shown on y-axis is the average similarity score at individual 
amino acid positions (x-axis) from multiple sequence alignments of Rsph4a and Rsph6a 
from major Vertebrates groups. The plots were generated with EMBOSS PlotCon using 






























































Figure 2.6 Rsph6a mRNA expression. (A) Schematic diagrams showing two 
mouse Rsph6a isoforms (I1 and I2). Isoform I2 is formed by splicing of a 765-bp exon in 
isoform I1. Numbers inside exons indicate exon order (bottom). Same color arrows indicate 
exon-specific forward and reverse primers designed along the length of the +Rsph6a gene 
(top). Numbers above each exon represent exon size. (B) Rsph6a gene expression analysis 




used for Rsph4a are listed in the Methods section. (C) Rsph6a gene expression analysis of 
mouse testes at various developmental ages by RT-PCR using exon-specific primers as 
shown in (A). For both RT-PCR reactions, β-actin was used as a loading control. (D) 
Quantitative PCR analysis on mouse testes using F4/R4 primers. Shown are pooled results 
from three biological replicates. For each biological replicate, three reactions were run per 
assay, and the same experiment was repeated on separate dates at least two times. For 
normalization, β-actin was run in parallel along with other tissues and the values obtained for 
4.0-week-old mouse testis were used as the “calibrator”; the 2^^-ΔΔCT method (fold change) 
was applied to report mRNA expression. Error bars represent the standard error of the means 
(±). Statistical differences in expression are indicated by asterisks (P < 0.05) when compared 
to Rsph6a expression found in 1- to 2-week-old mouse testes. (E) In situ hybridization 
showing expression of Rsph6a (left panel a and b) and Tssk6 mRNA (right panel c and d) in 
mouse testis sections. Black rectangular boxes represent enlarged portion (insets); black 
arrows show Rsph6a-positive secondary spermatocytes, and Tssk6-positive postmeiotic 



























































Figure 2.7 In situ analysis of Rsph6a and Tssk6 mRNA. (A)Rsph6a mRNA signal 
obtained in mouse testis sections when incubated with the corresponding sense (control) 
RNA probes. (B)Tssk6 mRNA in mouse testis sections when incubated with the 




















































Figure 2.8 Production of Rsph6a isoforms as His-tagged recombinant proteins. BL21 E. 
coli cells containing Rsph6a inserts were induced with 1 mM IPTG at 37°C for 4 h. Cell 
pellet harvested from 1 mL of bacteria culture was directly lysed in 50 μL 5X sample buffer 
and loaded onto 8% SDS-PAGE. A representative set of western blots of the experiments 
repeated at least three times and probed with Anti-His antibody is shown. Arrows indicate 


















Figure 2.9 Validation of a custom-made anti-Rsph6a antibody (E3). (A) Representative 
western blot showing detection of recombinant Rsph6a isoforms (I1 and I2) when 
incubated with E3 antibody alone (A, left panel) or in the in the presence of 200-molar 
excess of blocking peptide (P1) (A, right panel). (B) Protein lysates extracted from mouse 
sperm treated under capacitating (C) or noncapacitating (N) conditions were subjected to 
western analysis and detection of Rsph6a was done with mAb E3 antibody. In B (left 
panel), three distinct proteins are shown upon detection with mAb E3. Antibody 
competition with the E3 antigenic peptide (P1) is shown in B (right panel). PVDF 
membranes were stripped and sequentially probed with anti-tubulin antibody as loading 
control. (C) Immunofluorescence detection of Rsph6a in mouse sperm when probed with 
mAb E3 alone or in the presence of blocking peptide: (a, e) DIC images; (b) 
immunofluorescence with E3 alone or (f) when incubated with blocking peptide (E3-P1); 
(c) merged a-b; (d) inset showing magnified image from (c). Scale bars, 20 μm. Western 








Figure 2.10 Validation of anti-Rsph6a antibody (E2). Western blot showing detection of 
Rsph6a in recombinants (A) and in mouse sperm extracts (B) when probed with E2 
antibody alone or in the presence of blocking peptide P6. (C) Immunofluorescence 
showing localization of Rsph6a in mouse when probed with E2 antibody. (a, e) DIC 
images, (b) observed immunofluorescence with E2 alone or (f) when incubated with 
blocking peptide (E2-P6), (c) merged, (d) inset showing magnified image from (c). Scale 







































Figure 2.11 Rsph6a protein extraction and solubility analysis. For TritonX-100 extraction, 
sperm pellets were lysed in lysis buffer containing 1% TritonX-100, centrifuged, and 
separated into soluble (S) and insoluble (P) fractions. Separated fractions were then 
processed for western blotting as described in the Methods section. For sequential 
sample buffer extraction, sperm proteins were extracted in nonreducing (NR) condition; 
boiled, centrifuged, and soluble (S) and insoluble (P) fractions were separated. Proteins 
from insoluble fractions (P) were then further extracted with nonreducing (NR) SDS 
sample buffer (without added β-mercaptoethanol or DTT) or reducing (R) SDS sample 
buffer (with added 50 mM DTT). Proteins extracted in these conditions were then 
subjected to 8% SDS-PAGE for western blot analysis as described above in the Methods 
section. A representative western blot image of three independent experiments probed 
with E3 antibody is shown. For solubility controls, PVDF membranes were stripped and 
sequentially probed with anti-phosphotyrosine antibody (pY) for Hexokinase, and with 


































Figure 2.12 Identification of phosphorylated Rsph6a by two-dimensional gel 
electrophoresis. (A) 2D-PAGE of mouse sperm lysates under noncapacitating (NCAP) or 
(B) capacitating (CAP) conditions probed with mAb E3 antibody. (C) 2D-PAGE analysis 
of mouse sperm lysates incubated under capacitating conditions in the presence of 50 
μM H-89 inhibitor (CAP + H-89) or (D) 50 μM of LRE1 inhibitor (CAP + LRE1) probed with 
mAb E3 antibody. Numbers indicate the Rsph6a spots at different isoelectric points, and 
changes in phosphorylated Rsph6a are observed upon each treatment. Images are 















Figure 2.13 Model. (A) Schematic representation of the mouse sperm. The head and 
flagellar regions mid-piece, principal piece, and end piece are shown. A dotted line 
indicates the cross-section schematized in B. (B) Schematic representation of the 
principal piece cross-section. Fibrous sheath, outer dense fibers, and axonemal 
components are indicated. Numbers 1 to 9 indicate the microtubule doublet pair. C1 and 
C2 indicate the central pair of microtubules. Protein kinase A (PKA) is shown in the radial 
spoke stalk, and potential sites of phosphorylation of Rsph6a by PKA during sperm 


















Figure 3.1 PKA is involved in negative feedback control of cAMP synthesis. (A) A model 
adapted from the work of Nolan et al showing PKA mediated feedback control of cAMP 




sAC metabolizes ATP into cAMP molecule, which then activates PKA. Activation of 
cAMP/PKA pathway results in phosphorylation of several PKA substrates. To maintain 
balanced PKA signaling, PKA controls its own activity through regulated cAMP synthesis 
i.e. either by PKA mediated activation of PDE or inactivation of sAC. (B) A representative 
cAMP standard curve generated using known concentrations of cAMP. Sperm protein 
lysates were used as PKA source and stimulated with known concentrations of cAMP in 
vitro kinase assay. Values shown on the Y-axis are picomoles of 32P incorporated into 
Kemptide/min.106 sperm (specific PKA activity) were plotted against known 
concentrations of cAMP (X- axis) on logarithmic scale. Standard curve generated by this 
method was used to determine cAMP levels in unknown treatments by interpolation from 
their observed specific kinase activity values. (C-D) Involvement of PKA in negative 
feedback control of synthesis was determined by measuring intracellular cAMP levels. 
Sperm were incubated in a capacitating condition (media contain BSA and HCO3-) in the 
presence or absence of 30μM H-89 supplemented with or without 100μM IBMX for 60 
min. When using 1mM Rb-cAMPS or 30μM H-89 in (D) sperm were incubated in the 
presence of IBMX in capacitating condition. After capacitation, sperm were prepared for 
cAMP extraction. Extracted cAMP content was used to stimulate PKA in sperm lysate. 
Specific kinase activity obtained from each experimental condition was interpolated from 
cAMP standard curve in (B) to get cAMP levels. Data presented here are the means ± 
SE of at least three independent experiments, each performed in triplicates. Ordinary one-
way ANOVA following Tukey’s multiple comparison test was used to compare replicate 
































Figure 3.2 Rp-cAMPS blocks PKA activity in live cells as well as in vitro. (A) Sperm were 
incubated in capacitating condition (Cap, with HCO3- and BSA) for 60 min in the presence 
or absence of 1mM Rp-cAMPS. For positive control sperm were incubated with 30μM H-
89. Protein extracts obtained from each condition were run on 8% SDS PAGE and 
analyzed by western blot analysis. Immunodetection of PKA substrate phosphorylation 
was assessed by phospho PKA substrate antibody (pPKAS). Shown are the 
representative western blot images of the experiments repeated at least three times. (B) 
Sperm PKA activity was measured using Kemptide as a substrate. Triton-insoluble sperm 
lysates were incubated with or without 1mM Rp-cAMPS in the presence of 1mM cAMP in 
a kinase reaction. For position control, sperm lysates were incubated with 30μM H-89 
along with 0.1mM cAMP. Values shown on the Y-axis are picomoles of 32P incorporated 
into Kemptide/min.106 sperm for various experimental conditions. Data presented here 
are the means ± SE of at least three independent experiments, each performed in 
triplicates. Ordinary one-way ANOVA following Tukey’s multiple comparison test was 










Figure 3.3 Inhibition of calcineurin by CsA or FK506 blocks PKA substrate 
phosphorylation. Sperm were incubated in the absence or increasing concentrations of 
serine/ threonine phosphatase inhibitors for 60 min in capacitating (Cap, with HCO3- and 
BSA). To inhibit PP1 and PP2A, sperm were incubated with okadaic acid and calyculin A 
(A), and to inhibit calcineurin, FK506 (B) or cyclosporine A (C) was used. Protein extracts 
obtained from each condition were run on 8% SDS PAGE and analyzed by western blot 
analysis as described previously in “Experimental procedures” section. Immunodetection 
of PKA substrate phosphorylation was assessed by phospho PKA substrate antibody 
(pPKAS). Shown are the representative western blot images of the experiments repeated 












FIGURE 3.4 Calcineurin, FKBP12, and Cyclophilin A are Present in the Mouse Sperm. 
Cauda epididymal sperm were obtained by swim-out method as described in method 
section. Sperm pellet equivalent to 1–2 ×106 cells were lysed and subjected to SDS-
PAGE gel for western blot analysis by antibodies against calcineurin isoforms (A: (a) 
PPP3CA, (b) PPP3CB,  (c) PPP3CC), (d) PPP3R2), Cyclophilin A (C:(a)) and FKBP12 
(C:(b)). For positive controls, proteins from mouse brain and testis were extracted in ripa 
lysis buffer and protein lysate equivalent to 20μg proteins were analyzed by western blot 
analysis. (B) For immunofluorescence assays, sperm suspensions were fixed, air-dried 
on polylysine-coated coverslip, permeabilized and probed with mouse goat polyclonal 
PPP3CC antibody. Images shown are: (a) differential interference contrast (DIC), (b) 
observed immunofluorescence, (C) merge of a & b, (d) inset showing magnified image 
from (b). Scale bars, 20 μm. Western blot and immunofluorescence shown are the 




















Figure 3.5 CsA and FK506 do not inhibit PKA activity in live sperm and in vitro: (A, B) To 
evaluate specificity of CsA or FK506 in live cells, sperm were incubated in capacitating 
condition with 10 or 20μM CsA or 30 or 50μM FK506 alone or in the presence of 1mM 
db-cAMP/0.1mMIBMX for 60 min. For positive control, sperm were incubated with 30μM 
H-89 in the same manner as CsA or FK506. After capacitation, sperm proteins from each 
condition were extracted and subjected to SDS PAGE for western blot analysis. 
Immunodetection of PKA substrate phosphorylation was assessed by pPKAS antibody. 
Shown are the representative western blot images of the experiments performed at least 
three times. (C, D) To investigate specificity of CsA or FK506 in vitro, sperm PKA activity 
was measured using Kemptide its substrate. For this purpose, triton-insoluble sperm 
lysates were incubated at 30°C with or without 10μM CsA (C) or 50μM FK506 (D) in the 
presence of 0.1mM cAMP for 30min in 30μL kinase reaction. For positive control, sperm 
lysates were incubated with 30μM H-89 in the presence of 0.1mM cAMP. After completion 
of kinase reaction, PKA activity was recorded as counts per minute (CPM) and expressed 
as picomoles of 32P incorporated into Kemptide/min.106 sperm as shown in Y-axis. Data 
shown are the means ± SE of at least three independent experiments performed in 
triplicates. Ordinary one-way ANOVA following Tukey’s multiple comparison test was 










Figure 3.6 CsA and FK506 do not affect sAC activity in vitro as well as in live sperm: (A, 
B) Time course of sperm capacitation was initiated by incubating sperm in a capacitating 
media containing BSA and HCO3- in the presence of 10μM CsA or 30μM FK506. At 
indicated time points, sperm proteins were extracted and subjected to SDS PAGE for 
western blot analysis. Phosphorylation of PKA substrates were assessed by pPKAS 
antibody. Note that PKA substrate phosphorylation inhibition did not happen immediately 
after capacitation but it started to occur during 15-30 min of capacitation for both 
calcineurin inhibitors. Shown are the representative western blot images of the 
experiments performed at least three times. (C) To investigate if CsA affects sAC activity, 
in vitro cyclase assay was performed in 100μL total reaction containing 50μL sperm lysate 
supplemented with various constituent of cyclase buffer indicated in “methods” section. 
To stimulate sAC activity, 10 mM CaCl2 and 30 mM NaHCO3 were added. Additionally, 
10μL cyclosporine A or DMSO as control were included in the assay. After incubating the 
reaction mix for 30 min at 30 °C, the reaction was stopped, and sAC activity was 
determined by measuring the conversion of [α32P] ATP to [32P] cAMP. [32P] cAMP levels 




























Figure 3.7 Cav channel blockers do not affect PKA substrate phosphorylation. Sperm 
were incubated in capacitating condition (Cap, with HCO3- and BSA) for 60 min in the 
presence of (L-type; verapamil, T-type; mibefradil or NNC55-0936) Cav channel blockers. 
Concentration used are indicated in micromolar unit (μM). Protein extracts obtained from 
each condition were run on 8% SDS PAGE and analyzed by western blot analysis. 
Immunodetection of PKA substrate phosphorylation was assessed by phospho PKA 
substrate antibody (pPKAS). Shown are the representative western blot images of the 


































Figure 3.8 Inhibition of calcineurin by CsA or FK506 results in decreased cAMP levels. 
To evaluate the effect of CsA or FK506 on cAMP synthesis, sperm were incubated in a 
capacitating condition (media contain BSA and HCO3-) in the presence of 10μM CsA or 
30μM FK506 supplemented with 100μM IBMX for 60 min. After capacitation, sperm were 
prepared for cAMP extraction, and extracted cAMP content was then used to stimulate 
PKA in sperm lysate. Specific kinase activity obtained from each experimental condition 
was interpolated from cAMP standard curve as described previously (see Figure 3-1B) 
to get cAMP levels. Data presented here are the means ± SE of at least three independent 
experiments, each performed in triplicates. Ordinary one-way ANOVA following Tukey’s 





































Figure 3.9 Calcineurin inhibition by CsA affects sperm physiological functions. (Top 
panels) Sperm were incubated with 5μM or 10μM CsA in a capacitating condition for 60 
min. After capacitation, an aliquot of sperm suspension was subjected to CEROS 
Computer-assisted semen analysis (CASA) system as described in “methods” section. 
Data presented here are the means ± SE of at least three independent experiments (n=5). 
Ordinary one-way ANOVA following Tukey’s multiple comparison test was used to 
compare replicate means. *, p<0.001. For in vitro fertilization assays (bottom panels), 
sperm were capacitated in the presence or absence of 10μM CsA for 60 min. After 







containing at least 20-30 eggs. As a control for the effect of the CsA on eggs, eggs were 
preincubated with CsA and washed before insemination. To investigate the effect of the 
presence of CsA in all steps of IVF, sperm and egg were preincubated with CsA and CsA 
was also added in the fertilization drop. Fertilization was assessed by microscopic 
visualization of two-cell embryos. Data presented here are the means ± SE of at least 
three independent experiments (n=5). Ordinary one-way ANOVA following Tukey’s 








































































Figure 3.10 A model. Involvement of calcineurin in cAMP/PKA pathway. During normal 
capacitation event, sperm exposure to Ca2+/HCO3- activates sAC and increases cAMP 
levels, which then activates PKA. Activation of PKA leads to the downstream activation 
of signaling cascades. During this process, PKA also regulates its activity through direct 
or intermediary phosphorylation of sAC in negative feedback loop. (1). However, this 
process can be perturbed by two PKA inhibitors H-89 and Rp-cAMPS, the inhibition of 
which, results in elevated intracellular cAMP levels. Furthermore, calcineurin being a 
Ser/Thr phosphatase dephosphorylates sAC or intermediary substrates and fine tunes 
back PKA signaling through cAMP synthesis (2). However, this process is inhibited in the 



























Figure 4.1 Detection of CatSper channel in mouse sperm. (A) Cauda epididymal sperm 
from CatSper+/- and CatSper-/- were obtained by swim-out method as described in the 
methods section. Sperm pellet equivalent to 1–2 ×106 were lysed and subjected to SDS-
PAGE gel for western blot analysis by CatSper (D-17) antibody. Shown is a 
representative western blot image of the gel repeated five times. For immunofluorescence 
analysis sperm suspensions were fixed, air-dried on polylysine-coated coverslip, 
permeabilized and probed with the same antibody. Images from CatSper+/- sperm shown: 
(a) differential interference contrast (DIC), (b) observed CatSper (D-17) 
immunofluorescence, (c) merge of a & b, (d) inset showing magnified image from (b). 





immunofluorescence. Scale bars, 20 μm. Immunofluorescences shown are the 










Figure 4.2 Presence and localization of CaMKII in mouse sperm. Cauda epididymal 
sperm were obtained by swim-out method as described in the methods section. Sperm 
pellet equivalent to 1–2 ×106 incubated under noncapacitated and capacitated conditions 
were lysed and subjected to SDS-PAGE gel for western blot analysis by CaMKII antibody. 
Shown is the representative western blot image of five independent experiments (left 
panel). For immunofluorescence analysis sperm suspensions were fixed, air-dried on 
polylysine-coated coverslip, permeabilized and probed with same antibody. Images 
shown are: (a) differential interference contrast (DIC), (b) observed immunofluorescence, 
(C) merge of a & b, (d) inset showing magnified image from (b). Scale bars, 20 μm. 










Figure 4.3 Detection of CaMKII in human Sperm. (Left panel) Western blot analysis, on 
the protein lysates prepared from noncapacitated human sperm (~ 1–2 ×106 cells) probed 
with monoclonal rabbit CaMKII antibody. (Right panel) Immunofluorescence detection of 
CaMKII in human sperm. Images shown are: (a) differential interference contrast (DIC), 
(b) observed immunofluorescence, (C) merge of a & b, (d) inset showing magnified image 
from (b). Scale bars, 20 μm. Immunofluorescence shown is the representative images of 
































Figure 4.4 Detection of CaMKIV in mouse sperm. (A) Western blot analysis on the protein 






with monoclonal rabbit CaMKIV antibody. (B) For positive controls, proteins from mouse 
brain and testis were extracted in RIPA lysis buffer and protein lysates equivalent to 20μg 
of proteins were analyzed by western blot analysis. (C) Immunofluorescence detection of 
CaMKIV in noncapacitated mouse sperm. Images shown are: (a) differential interference 
contrast (DIC), (b) observed immunofluorescence, (C) merge of a & b, (d) inset showing 
magnified image from (b). Scale bars, 20 μm. Immunofluorescence shown is the 









































Figure 4.5 Detection of CaMKIV in human sperm. (Left panel) Western blot analysis on 
the protein lysates prepared from noncapacitated human sperm (~ 1–2 ×106 cells) probed 
with monoclonal rabbit CaMKIV antibody (left panel). (Right panel) Immunofluorescence 
detection of CaMKIV in human sperm (right panel). Images shown are: (a) differential 
interference contrast (DIC), (b) observed immunofluorescence, (C) merge of a & b, (d) 
inset showing magnified image from (b). Scale bars, 20 μm. Immunofluorescence shown 














Figure 4.6 Detection of Calmodulin in mouse and human sperm. Western blot analysis 
on the protein lysates prepared from noncapacitated and capacitated mouse sperm (left 
panel) and noncapacitated human sperm (~ 1–2 ×106 cells) (middle panel) probed with 
monoclonal mouse CaM antibody. Immunofluorescence detection of CaM in 
noncpacitated mouse sperm (right panel). Images shown are: (a) differential interference 
contrast (DIC), (b) observed immunofluorescence, (C) merge of a & b, (d) inset showing 
magnified image from (b). Scale bars, 20 μm. Immunofluorescence shown is the 































Figure 4.7 Solubility analysis of Ca2+ signaling molecules in mouse sperm. Cauda 
epididymal sperm from CatSper+/- and CatSper-/- were obtained by swim-out method as 
described in the methods section. Sperm pellet equivalent to 1–2 ×106 were lysed using 
RIPA lysis buffer containing 1% Trition X-100 and 0.1% SDS and subjected to SDS-PAGE 
gel for western blot analysis by various antibodies. For solubility control, the same 




















Figure 4.8 Regulation of CaMKII during sperm capacitation. (A) Time course of sperm 
capacitation was initiated by incubating sperm in a capacitating media containing BSA 
and HCO3-. At indicated time points, sperm proteins were extracted and subjected to SDS 
PAGE for western blot analysis. Activation of CaMKII was assessed by pCaMKII (Thr286) 
antibody. For loading control, membranes were stripped and probed for CaMKII total 
protein. (B) Assessment of dependence of CaMKII on extracellular Ca2+ was done by 
capacitating sperm in the presence Ca2+, no added Ca2+ ([Ca2+]free) or [Ca2+]free  in the 
presence of 1mM EGTA. At indicated time points proteins were extracted and effect of 

















Figure 4.9 Inhibition of CaMKII by KN93 or CamKIINtide blocks PKA substrates 
phosphorylation. To evaluate the role of CaMKII in cAMP/PKA pathway, sperm were 
incubated in 20μM KN93 (A) or 5 or 10μM CamKIINtide (C) for 60 min in a capacitating 
condition (Cap, with HCO3- and BSA). Moreover, in the same experiment, off target effect 
of KN93 or CamKIINtide on PKA was evaluated by incubating sperm with same 




cAMP/0.1mM IBMX for 60 min. For positive control, sperm were incubated with 30μM H-
89 in the same manner. After capacitation, sperm proteins from each condition were 
extracted and subjected to SDS-PAGE for western blot analysis. Immunodetection of 
PKA substrates phosphorylation was assessed by pPKAS antibody. To investigate 
specificity of KN93 or CamKIINtide in vitro, sperm PKA activity was measured using 
Kemptide as its substrate. For this purpose, triton-insoluble sperm lysates were incubated 
at 30°C with or without 20μM KN93 (B) or 10μM CamKIINtide (D) in the presence of 
0.1mM cAMP for 30min in 30μL kinase reaction. For positive control, sperm lysates were 
incubated with 30μM H-89 in the presence of 0.1mM cAMP. After completion of kinase 
reaction, PKA activity was recorded as counts per minute (CPM) and expressed as 
picomoles of 32P incorporated into Kemptide/min.106 sperm as shown in Y-axis. Data 
shown are the means ± SE of at least three independent experiments performed in 
triplicates. Ordinary one-way ANOVA followed by Tukey’s multiple comparison test was 














Figure 4.10 Inhibition of CaMKII by KN93 inhibits sperm hyperactivation. Sperm were 
incubated with or without 20μM KN93 or in the presence of KN93 and 100μM db/cAMP 
in a capacitating condition for 60 min. After capacitation, an aliquot of sperm suspension 
was subjected to CEROS Computer-assisted semen analysis (CASA) system as 
described in the “methods” section. Data presented here are the means ± SE of at five 
independent experiments. Ordinary one-way ANOVA followed by Tukey’s multiple 
comparison test was used to compare replicate means. (A) % Motility, (B) % Progressive 
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